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Forward 
 
 
ADMA has great pleasure in welcoming you all to this important meeting.  As healthcare providers working 
for people with chronic disease, it is vital we share our disease management healthcare models and findings to 
promote sustainability and embed credible disease management services in our healthcare system.  
 
Disease Management seeks to improve client quality of life and reduce hospital admissions and emergency 
department presentations for people with chronic disease. The need for disease management healthcare for 
people with chronic disease is increasingly significant with the burden of disease, an ageing population and the 
demand for hospital beds. It also, importantly, means better care for Australians with chronic conditions such 
as asthma, chronic heart failure, chronic respiratory disease, and diabetes. Further early detection and 
identification of chronic disease will assist in containing the escalation of these diseases in the Australian 
population. There is also impact on other sectors outside the health system such as workplaces and carers. 
 
Disease Management is in its infancy in Australia, however, it is an exciting and rewarding approach to 
healthcare. Many disease management services now provided across Australia are assisting clients to stay well 
at home and out of hospital. These services are being provided by you and your teams, dedicated health care 
providers. I congratulate those providing quality care with effective and positive outcomes for clients and our 
healthcare system. The Disease Management approach now requires us all to report on its outcomes to assist 
in its sustainability and credibility.  
 
We welcome all of the speakers who are presenting their expertise and experience. ADMA is pleased to have 
the inclusion of our international key note speakers Mr Alan Doran from the NHS in the UK, Dr Peter 
Sargious from Canada and Dr Gary Sinclair from New Zealand, and we welcome them to Australia. ADMA 
also thanks our national key note speakers, Prof Gavin Andrews from University NSW, Prof Jim Butler, 
Australian National University, Ms Linda Powell from the Department of Health and Ageing, Dr David Preen 
from University of WA, Dr Margarite Vale from St Vincents Melbourne, A/Prof John Wakerman from Flinders 
University and Prof Richard Wootton from the Centre for Online Health, University of Queensland. 
 
We thankyou for your participation and welcome your feedback on this conference and your suggestions for 
future conferences. Please enjoy the conference and the opportunity to visit the exhibitors’ booths, the poster 
presentations and network with your colleagues.  
 
Dr Marco Bonollo MBBS, FRACP     
Chair, Australian Disease Management Association   
 
Ms Kaylene Fiddes 
Exec Director, Australian Disease Management Association 
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About ADMA 
 
 
The Australian Disease Management Association (ADMA) provides a forum and advocacy for the 
disease management industry to promote programs which improve chronic condition outcomes and quality of 
life and reduce acute healthcare utilisation and costs. ADMA consults stakeholders in the industry and 
educates healthcare organisations, providers, funders and healthcare policy makers on disease management.  
 
There are currently many disease management initiatives under way across Australia. These are occurring in 
the private and public sectors and are being funded by state and commonwealth government initiatives, grants 
and service negotiations. There are various models or components to Disease Management which include 
self-management, behaviour change, health risk assessments, telephone coaching, clinic based programs, 
outreach based programs and online initiatives.  
 
ADMA supports work in the area of disease management and provides resource to assist ongoing 
development, implementation and sustainability. ADMA collaborates with services across Australia and seeks 
to foster information exchange between all Australian disease management services so we can all learn from 
each other.  
 
ADMA activities include, but are not limited to: 
• the ‘DM Line’ - a national e-mail information exchange forum 
• distribution of quarterly newsletters 
• collation of a comprehensive literature database 
• a Web Page 
• quarterly publication of the "DM Review" which summarises recent relevant publications 
• a range of metropolitan and rural seminars and workshops 
• a National Conference. 
 
Advisory committee 
 
The ADMA Advisory committee consists of 
Dr Marco Bonollo [Chair]    Dr Lisa Demos 
Ms Kaylene Fiddes    Mr Dan Hook 
Prof Nick Santamaria    A/Prof Lexie Spehr 
 
 
Conference Committee  
 
The 2006 ADMA national conference committee consists of 
 
Ms Zoe Austin-Crowe Victorian Department of Human Services 
Dr Matthew Cullen  Co-Director McKesson Asia-Pacific 
Dr Lisa Demos  ADMA 
Ms Kaylene Fiddes ADMA 
Ms Marion Osborn         ADMA 
 
ADMA gratefully appreciates the time and effort of conference committee members in putting this conference 
together and chairing sessions. ADMA also gratefully acknowledges the work of Marion Osborn on this 
conference.  
 
Special thanks also to Nadine Hutchins, Megan Rivers and Dipak Sanghvi from the Pharmacy Guild of Australia 
for their contribution to this conference. The Guild’s Victorian President, Mr Dipak Sanghvi will kindly chair 
the session arranged by the Guild.  
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Program at a glance – Day 1: 7th September 2006 
 
 Chair: Ms Kaylene Fiddes   
 
Room: PROMENADE  
0900 – 0915 Welcome: Dr Marco Bonollo, Chair Australian Disease Management Association 
Opening: The Hon Bronwyn Pike, Victorian Minister for Health 
 
0915- 0955 Evidence based disease management – chronic care models in action in Counties Manaukau 
Dr Gary Sinclair, Clinical Director Primary Care and CCM, Counties Manukau NZ 
0955- 1035 A review of the evidence for the value of home monitoring in chronic disease management 
Prof Richard Wootton, Director Research, Centre for Online Health, Uni of Queensland 
1035-1100 Morning Tea 
 
 Chair: Dr Matthew Cullen,  
 
Room: M 1 & 2 
Chair: Dr Lisa Demos, ADMA 
 
Room:  PROMENADE  
Chair:  Prof Nick Santamaria,  
 
Room:  M 3 & 4 
1100-1120 Using an e-disease 
management system to 
remotely monitor mental 
health after a natural 
disaster: experiences from 
an innovative trial 
Dr Robin Harvey, Research 
Manager, Sentiens Pty Ltd 
Community based interventions 
for secondary stroke prevention 
– what are the elements that 
work?  
Dr Jacques Joubert, Neurologist, 
Melbourne Health and National 
Ageing Research Institute  
How to get executive buy 
in? Demonstrating the 
savings of Ambulatory 
Care and Disease 
Management in WA 
Dr Shirley Bowen, 
Executive Director 
Population Health and 
Ambulatory Care, North 
Metropolitan Area Health 
Service, WA DOH 
1120-1140 Role of call centres in 
disease management – a 
review of the literature 
Dr Andrew Wilson, Co-
President, McKesson Asia-
Pacific Pty Ltd 
Impact of a community based 
multidisciplinary chronic heart 
failure program on hospital 
admissions in complex elderly 
patients 
Ms Peita Price, CHF Community 
Nurse, Moreland Community 
Health Centre  
Optimising the potential 
impact of care coordinating 
models for people with 
chronic and complex 
conditions 
Dr Deborah Roberts & Dr 
Catherine Joyce, Dept 
Epidemiology & Preventive 
Medicine, Monash Uni 
1140-1200 Managing chronic disease 
and the remote monitoring 
of health status of the elderly 
at home 
Prof Branko Celler, Director 
Laboratory Health Infor-
matics and Head School of 
Electrical Engineering & 
Telecommunications, Uni 
NSW. Ms Janette Gogler, 
Austin Health VIC  
Chronic Pulmonary Obstructive 
Disease – a unique community 
linkage service 
Ms Karen Thomas, Perth and 
Hills Division of General 
Practice WA 
Evaluating a statewide 
chronic care program – 
was there an 
improvement? 
Ms Poppy Doungkamol 
Sindhusake, Centre for 
Health Services Research, 
Western Sydney Area 
Health Service & School 
Population Health, Uni of 
Sydney 
1200-1220 Multicultural Information on 
Depression online 
(MIDonline): Development 
and evaluation of a 
multilingual depression 
information website 
Dr Litza Kiropoulos, 
Research Officer, Dept 
General Practice, Monash 
Uni 
Are Chronic Heart Failure 
Management Programs 
optimising patient outcomes? 
Ms Andrea Driscoll, PhD 
Candidate, NHMRC Scholar, 
Deakin Uni 
National online disease 
management survey 
Mr Bobby Amin, Research 
Assistant, Dept 
Epidemiology and 
Preventive Medicine, 
Monash Uni 
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1220-1230 Question time 
 
1230-1330 
 
Lunch 
 Chair: Dr Lisa Demos, ADMA 
 
Room: M 1 &  2 
Chair: Dr Matthew Cullen  
 
Room: PROMENADE 
Chair: Mr Dan Hook,  
 
Room: M 3 & 4 
1330-1350 The emergence of Tai Chi as 
an acceptable and effective 
exercise approach in 
improving health outcomes 
for older people 
A/Prof Keith Hill, Director, 
Preventive and Public Health 
Division, National Ageing 
Research Institute 
Selective outcomes from a 
respiratory coordinated care 
program (RCCP) providing 
community based interventions 
for COPD patients for 2005 
Mr Nick Spiliopoulos, NUM, The 
Respiratory Coordinated Care 
Program, St George Hospital 
Internet based approaches 
to behaviour change in 
disease prevention and 
management 
Dr Michael McCoy, 
Managing Director, 
Fitness2Live VIC 
1350-1410 Integrative and 
complementary approaches 
to the management of 
chronic diseases? 
Dr Vicki Kotsirilos, GP and 
Past Founding President, 
Australasian Integrative 
Medicine Association (AIMA) 
 
Keeping track of diabetes – 
measuring outcomes of a pilot 
diabetes disease management 
program in a private health 
insurance population 
Ms Virginia Hagger, Director 
Education, International 
Diabetes Institute & Ms Julie 
Andrews, Manager, Health 
Development Unit, Medibank 
Private 
Workplace health and 
productivity management 
as a serious economic 
strategy 
Dr Shirley Musich, 
Director, Health and 
Productivity Research 
Centre, Wollongong Uni 
1410-1430 The getting around gracefully 
program 
Mr Robert Webb, 
Feldenkrais Practitioner, 
Moreland Community 
Health Service 
Diabetes Direct Delivers 
Ms Jacinta Collins, Project 
Manager, Northern Division of 
General Practice 
Future trends in corporate 
healthcare 
Dr Jonathon Orelowitz, 
Director, Healthlogix Pty 
Ltd 
1430-1450 Integrative medical 
approaches to primary and 
secondary prevention of 
cardiac disease 
Dr Gary Deed, Medical 
Practitioner, Integrative 
Medicine Your Health, 
Brisbane 
Snakes and ladders: the 
challenges and triumphs of 
improving diabetes care in 
Melbourne’s West 
Ms Naomi Kubina, Project 
Officer, WestBay Alliance 
Newport 
Evidence based care and 
prioritisation of people 
waiting for elective hip and 
knee replacement surgery: 
the new Victorian 
management and 
prioritisation system 
Ms Catherine Jones, 
Centre for Rheumatic 
Diseases, Royal Melbourne 
Hospital, Uni of Melbourne 
1450-1500 Question time 
 
1500-1530 
 
Afternoon tea 
 Chair:  Prof Nick Santamaria                            
 
Room: PROMENADE 
1530-1615 Chronic Disease Management in the Australian Community Setting: Evaluation Using Cross- 
Jurisdictional Record Linkage 
Dr David Preen, Research Fellow, School of Population Health, Uni of Western Australia 
1615-1700 The COACH Program: an evidence based, telephone delivered, disease management program 
proven to reduce hospital admissions in patients with coronary heart disease 
Dr Margarite Vale, Director, COACH Program, Dept Cardiology and Uni of Melbourne Dept 
Medicine, St Vincents Hospital VIC 
 
1700 
 
Cocktail party.  
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Program at a glance – Day 2: 8th September 2006 
 Chair: Dr Marco Bonollo                                            
 
Room: PROMENADE 
0900 - 0910 Welcome 
 
0910-0955 Closer to Home – Shifting Care in England 
Mr Alan Doran, Director General, Departmental Management, Department of Health, UK 
0955-1030 Chronic Disease Prevention and Treatment – cost benefit model systems to assist with 
priority setting 
Prof Jim Butler, Australian Centre for Economic Research on Health, Australian National Uni 
ACT   
1030-1100 Morning Tea 
 
 Chair:  Dr Matthew Cullen 
 
 
Room: PROMENADE 
 Chair: Mr Dipak Sanghvi, President, Victorian Branch 
Pharmacy Guild of Australia 
 
Room: M 3 & 4 
1100-1120 Auditing Cardiac Rehabilitation 
Programs – Pitfalls and Pluses 
Ms Narelle Wilson, Royal Perth 
Hospital 
 Disease State Management Programs in 
community retail pharmacy – hosted by the 
Pharmacy Guild of Australia 
1120-1140 Are chronic disease self 
management programs 
generalisable across conditions? 
Ms Virginia Hagger, Director 
Education, International Diabetes 
Institute 
1100-
1130 
Diabetes 
Mr Lance Emerson, Director Programs & 
Professional Development, The Pharmacy 
Guild of Australia and Mr Brendan 
O’Loughlin, St Ives Pharmacy, Sydney 
1140-1200 Who benefits most from 
participating in chronic disease 
management programs? 
Ms Sandra Nolte, Collaborative 
Institute Research, Consulting and 
Learning in Evaluation, RMIT Uni & 
AFV Centre for Rheumatic 
Diseases, Uni of Melbourne 
1130-
1200 
Asthma 
Prof Carol Armour, Pharmacy Faculty, Uni of 
Sydney and community pharmacy specialist in 
Guild Asthma Program NSW 
1200-1220 Chronic Disease Self Management 
programs – what is the evidence? 
Ms Sharan Ermel, Research 
Assistant, Collaborative Health, 
Education and Research Centre 
(CHERC) Bendigo Health Care 
Group 
1200-
1230 
Smoking Cessation 
Ms Jenny Bergin, Chief Pharmacist, The 
Pharmacy Guild of Australia and community 
pharmacist specialist smoking cessation 
programs 
1220-1230 Question time   
 
1230-1330 
 
Lunch 
 Chair: Dr Marco Bonollo                                                       
 
Room: PROMENADE 
1330-1400 CLIMATE.tv chronic care without tears 
Prof Gavin Andrews WHO Collaborating Centre, Uni NSW at St Vincents Hospital NSW 
1400-1430 Sustaining chronic disease management in remote Aboriginal Communities 
A/Prof John Wakerman, Director, Centre for Remote Health, Flinders Uni 
1430-1500 Chronic Disease – A Head on Tackle 
Ms Linda Powell, Assistant Secretary, Chronic Disease and Palliative Care Branch, Dept of 
Health and Ageing, ACT 
1500-1530 Afternoon tea 
1530-1600 Canadian Perspectives on disease management 
Dr Peter Sargious, Medical Leader, Chronic Disease Management, Calgary Health Region, 
Canada 
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 Chair: Prof Nick Santamaria 
 
Room: PROMENADE  
Chair: Dr Lisa Demos, ADMA  
 
Room: M 3 & 4 
1600-1620 To integrate or not to integrate? Future 
considerations for chronic disease self 
management programs in the healthcare 
system 
Ms Joanne Jordan, AFV Centre for 
Rheumatic Diseases, Uni of Melbourne  
Improving care for people with osteoarthritis: 
implementation and evaluation of a multi-
disciplinary osteoarthritis service at Royal 
Melbourne Hospital 
Dr Caroline Brand, Director Clinical 
Epidemiology and Health Service Evaluation Unit, 
Melbourne Health 
1620-1640 Acceptability, impact and sustainability of 
the national pilot quality assurance 
system for self management programs 
Ms Joan Nankervis, AFV Centre for 
Rheumatic Diseases, Uni of Melbourne 
Improving mobility in patients with Parkinsons 
Disease 
Prof Meg Morris, Director Allied Health Clinical 
Research at Southern Health RASP and Prof 
Physiotherapy at Uni of Melbourne 
1640-1700 The Australian experience of telephonic 
disease management –a new mode of 
delivery 
Ms Julie Muir, Disease Management Team 
Leader, McKesson Asia Pacific 
Managing the medications: impact of a clinical 
pharmacist in a disease management unit 
Ms Robyn Stell, Pharmacist, The Alfred, 
Melbourne 
1700 Announcements, Awards, Close – Ms Kaylene Fiddes ADMA  
 
Room: PROMENADE 
 
 
Day 1: 7th September 2006 
 
 
0910AM 
Evidence based disease management – chronic care models in action in Counties Manaukau 
Presenter: Dr Gary Sinclair, Clinical Director Primary Care and CCM, Counties Manukau 
NZ 
 
The CCM programme in Counties Manukau presently delivers evidenced based disease management for five 
disease modules, diabetes, cardiovascular disease, COPD, congestive heart failure and depression. The 
programme is based on an “expanded” Wagner Chronic Care Model, and uses a modified Kaiser approach to 
service delivery. The clinical evidence base for each module is based on guidelines published by the New 
Zealand Guidelines Group. Using Wagner’s six pillars, the presentation outlines current disease management 
activity in Counties Manukau and presents an overview of some of the outcomes. 
 
 
0950AM 
A review of the evidence for the value of home monitoring in chronic disease management 
Presenter: Professor Richard Wootton, Director of Research, Centre for Online Health, 
Uni of Queensland, QLD 
 
We undertook a systematic review of home telehealth using several electronic databases.  We selected only 
scientifically valid studies that compared a home telehealth intervention with a non home telehealth 
alternative, and reported outcomes in terms of administrative changes, patient management decisions, patient 
outcomes, economic impact or social impact on patients or carers.  We excluded studies that dealt with 
paediatric, neonatal or obstetric home care.  The search identified 5120 potential references, of which 103 
reported controlled studies, related to 17 diseases or conditions, that met our selection criteria.  There was 
evidence for clinical effectiveness in the areas of cardiac disease (including congestive heart failure), diabetes 
and mental health.  Application of home telehealth to smoking cessation emerged as an additional area where 
there is reasonable evidence of clinical effectiveness.  Most publications (95%) reported investigations in terms 
of patient outcomes with a high proportion of short term studies.  Less than 20% included economic analysis 
and most of these were cost studies of limited quality.  Home telehealth practice had advantages over the 
alternative approach in 88 studies (85%).  While there are still limited numbers of good quality studies, the 
evidence supporting the application of home telehealth to number of diseases/conditions is growing.  
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1100AM 
Using an e-disease management system to remotely monitor mental health after a natural 
disaster: experiences from an innovative trial 
Presenter:   Dr Robin Harvey, Research Manager, Sentiens Pty Ltd WA 
Authors:  Harvey, R12, Smith, M12 , Tannenbaum, D1 
1 Sentiens Pty Ltd  2 Uni of WA 
 
Mid to late 2005 was a period of unprecedented hurricane activity in the Gulf of Mexico with the advent of 
three of the six most intense Atlantic hurricanes in recorded history (Hurricanes Katrina, Rita, and Wilma). 
The rapid succession of these hurricanes is likely to have intensified the psychological impact of the disasters 
as infrastructure that survived previous storms was destroyed, rebuilding efforts were restricted, and 
stressors on survivors were exacerbated and drawn out over a longer period. In response to this disaster a 
community choir was formed, made up of survivors of the hurricane disaster.  Given the musical heritage of 
Louisiana, this project was framed within the context of a community initiative, and it was expected that 
participation in the choir assisted hurricane survivors to feel increased social support, a greater sense of 
community cohesion and lead to improved perceptions of coping and optimistic thinking. Using the online 
monitoring facility developed by Perth-based health company, Sentiens Pty Ltd., it was possible to develop and 
implement a mental health monitoring system that could track the psychological wellbeing of choir 
participants. Changes in the severity of depression, anxiety and PTSD symptoms in hurricane survivors during 
the period of the project were tracked (with other attitudinal measures). This research project demonstrates 
how information systems can be flexibly applied in health research to the benefit of most communities, be 
they located: on the other side of the planet, rural, remote, or metropolitan.   
 
1100AM 
Community based interventions for secondary stroke prevention – what are the elements that 
work?  
Presenter: Dr Jacques Joubert, Neurologist, Melbourne Health and National Ageing 
Research Institute VIC 
 
Risk factors for stroke have been identified and their management well-researched, however translation of 
best-practice guidelines into primary care has been disappointing. This is despite the fact that implementation 
of best-practice management would significantly reduce stroke risk.1, 2  
Prevention of recurrent stroke is essential to minimize the long-term risk of increased, stepwise disability and 
vascular death in stroke survivors.3  Post-stroke depression is being recognized as a risk factor for long-term 
stroke mortality.4 
We report the development of a successful integrated care model for management of vascular risk factors and 
the detection of post-stroke depression in a community setting.5 
We initially applied a "case-management" model, centered on nurse case coordination who provided linkage 
between hospital, general practitioners and patient carers. 
This model resulted in successful modification of cardiovascular risk factors with trends in normalization 
approaching statistical significance with hypertension and cholesterol.  
In parallel depression was identified and quantitatively assessed over time as part of a prospectively 
randomized intervention trial.4  Changes in the trial arm were significantly different to the "usual-care " arm. 
Economic analysis of the case-management model established that it was not economically sustainable under 
normal practice conditions due to costs of labour.  
We therefore developed a variant of the recent WHO classification of Models of Community Care 6  
characterized by patient and carer empowerment, GP enablement and telephone-based case coordination.  
An exploratory trial was performed establishing the efficacy of the integrated  management model for 
cardiovascular risk factors and modification of depression. We are proceeding to a Definitive Randomized 
Control Trial.  
1.  Hachinski V. Stroke. 2002;33:1-4.  
2. Yusuf S. The Lancet. 2002;360:2-3 
3. Hardie Ket al. Stroke. 2003;34:1842-1846. 
4. Everson SA et al. Arch Intern Med   1998; 158: 1133-1138. 
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1100AM 
How to get executive buy in? Demonstrating the savings of Ambulatory Care and Disease 
Management in WA 
Presenter: Dr Shirley Bowen, Executive Director Population Health and Ambulatory Care, 
North Metropolitan Area Health Service, WA Dept of Health, WA 
 
Getting the Chief Executive to understand that a ‘hospital is not a health care system’ can be difficult! To 
confront traditional models of care a robust cost-benefit analysis of the impact of chronic disease care on the 
acute sector is required. This paper will outline the type of economic analysis required to demonstrate the 
impact of chronic diseases in terms of disease category, bed days utilised and outpatient visits on the acute 
sector in WA. When compared with the cost and health outcomes of community based disease management 
and strategies to prevent admission and deterioration the benefits of disease management cannot be ignored. 
An outline of how to market these outcomes and new models to the Executive will also be provided.  
 
1120AM 
Role of call centres in disease management – a review of the literature 
Presenter: Dr Andrew Wilson, Co-President, McKesson Asia-Pacific Pty Ltd NSW 
Authors: Wilson A, Cullen M. McKesson Asia-Pacific  
 
The use of call centre technology in the health system is expanding. The call centre model provides the 
consumer and carers with enhanced information (eg. advice on managing a chronic illness, a mental illness or 
referral options) as well as providing protocol driven triage assessments that have the potential to impact 
positively on clinical care. Health call centres are increasingly being used for a variety of functions – 
• Assist patients with administrative tasks (e.g follow-up visit reminders) 
• Monitor patients to identify health and behavioural problems 
• Deliver patient education or other disease management counselling 
• Facilitate informal support (such as peer support) for coping with illness 
Chronic Disease Management is shown to provide benefits in terms of improved outcomes and decrease in 
costs. Health call centres can enhance a Chronic Disease Management service delivery model through Access, 
Clinical Decision Support System, Coordinated care, Risk stratification, Patient education and Monitoring. 
Results will be presented that demonstrate a range of services, disease impacted outcomes and future 
directions 
Clinical indicators include clinical measurement, educational measurement, outcomes measurement, disease 
indicators and quality indicators. Current research indicated approximately 20-30% decrease in healthcare 
utilisation following health call centre delivered programs. Across several diseases including heart failure, 
diabetes, asthma, there were found to be substantial reductions in hospitalisations, inpatient bed days, fewer 
outpatients, emergency department visits, 30 day readmissions and costs. For example, outcomes from a heart 
failure study reported 23% fewer hospitalisations, 70% fewer 30-day readmissions and 17% lower costs. 
Similarly, an asthma disease management study reported 50% fewer impatient bed days, 28.2% fewer ED visits 
and 6.2% fewer hospital outpatient units. The applicability of this within the Australian public/private context 
will be discussed. 
 
1120AM 
Impact of a community based multidisciplinary chronic heart failure program on hospital 
admissions in complex elderly patients 
Presenter: Ms Peita Price, CHF Community Nurse, Moreland Community Health Centre 
VIC 
Authors:  Price P1, Ryan M1, Collins, J. Bain, C. Bowyer, A. Grigg, L2, Joshi, S2 
1Moreland Community Health Centre, Coburg, Vic 2Clinical Epidemiology Department and 
Cardiology Department, Royal Melbourne Hospital 
  
Multidisciplinary chronic heart failure (CHF) programs have been shown to reduce hospital readmissions in 
patients without other serious medical illnesses. Their usefulness in elderly patients with more complex care 
needs has not been well established. The aim of this study was to assess the impact of a community based 
multidisciplinary CHF program in an unselected elderly and complex patient group. The study population 
consisted of consecutive patients referred over a 12 month period to the Heartwise CHF program based in 
Coburg, Victoria.  The total number of hospital admissions during the 6 month periods before and after 
enrolment in the program was determined from hospital records. There were 77 patients with a mean age of 
77 years. 65% of patients had ≥ 2co-morbid medical conditions in addition to CHF (COPD, diabetes, chronic 
renal failure, peripheral vascular disease, stroke or depression), 61% of patients spoke English as a second 
  11 
language. The results of this program will be presented showing the changes in admissions and beddays pre 
and post. Community based multidisciplinary heart failure programs can be highly effective in reducing hospital 
readmissions even in elderly patients with complex care needs.  This study highlights the need for broader 
access to community based disease management programs.   
 
1120AM 
Optimising the potential impact of care coordinating models for people with chronic and 
complex conditions 
Presenter: Dr Deborah Roberts & Dr Catherine Joyce, Dept Epidemiology & Preventive 
Medicine, Monash Uni VIC 
 
Objectives: To explore simulation modeling methods for projecting potential impact of emerging ‘care 
coordinating’ models for people with chronic and complex conditions.  
Methods:  
1. Review literature on ‘care coordinating models’ including disease management, case management and 
population health management.   
2. Present case studies of such models being piloted or implemented in the Australian health care system  
3. Investigate the potential for simulation modelling methodology as a method of comparing different ‘care 
coordinating’ models to inform policy and practice.   
Principal findings: While there is increasing discussion about ‘care coordinating models’ for people with 
chronic and complex conditions, to date no single approach has been explicitly accepted as the preferred 
option in the Australian context, and implementation of formal models remains implicit, localized and small 
scale, or adhoc and limited to certain sectors of the health care system (for example, aged care).  
Simulation modelling has been used to project future demand for services, and to estimate workforce 
requirements and service costs. This methodology would be applicable to the question of how different care 
coordinating models compare. Using simulation modelling, the workforce requirements, skill mix (training, 
competencies and functional roles), funding structures and costs associated with various models could be 
evaluated without the need for expensive, lengthy, and logistically difficult trials. 
Discussion: While some elements of primary health care in Australia are implicitly based on particular models 
of care for people with chronic and complex conditions (for example the newly initiated Chronic Disease 
Management MBS items based on a disease management model), to date there has been little research directly 
comparing formal models of care.  Simulation modelling offers an efficient method for generating evidence 
regarding the likely workforce requirements, skill mix, funding structures and costs associated with 
widespread implementation of care coordinating models.  
Implications for policy, delivery or practice: If we are to successfully move from conversations about the 
conceptual frameworks to implementation of ‘care coordinating models’ for people with chronic and complex 
conditions, we will need to plan carefully for the changed health workforce requirements associated with 
these new ways of working. Simulation modelling studies can contribute to more evidence-informed policy 
decisions about health workforce requirements in the application of emerging models of care.  
 
1140AM 
Managing chronic disease and the remote monitoring of health status of the elderly at home 
Presenters: Prof Branko Celler, Director Laboratory Health Informatics and Head School of 
Electrical Engineering & Telecommunications Uni NSW and Ms Janette Gogler, 
Austin Health VIC 
 
Chronic disease and the clinical consequences of exacerbations of chronic disease now account for >75% of all 
healthcare expenditure in developed countries. In the context of rapidly ageing populations the cost effective 
management of chronic disease must therefore be a very high priority.  
We will present our research, development and deployment of comprehensive home telecare services that 
promote high user acceptance and adherence and facilitate high levels of self care and self management. The 
Telemedcare system has been developed to support a range of hospital and community wide programs 
designed to improve self management at home, reduce hospital admissions and reduce length of stay in 
hospital.  
The Telemedcare system is designed with some fundamental principles in mind. (i) acute exacerbations of 
chronic disease usually manifest themselves over a number of days or even weeks before an acute episode, (ii) 
compliance falls the more inconvenient the intervention, and (iii) technical problems multiply dramatically with 
long term continuous monitoring.  
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The Telemedcare system therefore seeks to provide a comprehensive home care facility that requires less 
than 20 minutes a day of patient interaction and provides daily logs, questionnaire instruments, health 
education and medications management as well as clinical measurements. 
The Telemedcare systems is being deployed in a major trial at the Austin Hospital funded by the Victorian 
Department of Human Services as part of its HARP program. Implementation issues, patient and clinician 
acceptance and customisation issues, as well as impact on clinical human resources and clinician work 
practices, arising out of this deployment will be presented.  
 
 
1140AM 
Chronic Pulmonary Obstructive Disease – a unique community linkage service 
Presenter: Ms Karen Thomas, Respiratory Nurse Specialist, Perth and Hills Division of 
General Practice WA 
Authors: Thomas K, Gaebler S, Bulsara C. Perth and Hills Division of General Practice WA 
 
A needs analysis performed for the East Metropolitan Population Health and Canning and Perth and Hills 
Divisions of General Practice identified a lack of access to Community based specialist assessment, ongoing 
community based pulmonary rehabilitation, and lack of knowledge / communication regarding Chronic 
Obstructive Pulmonary Disease (COPD) management. These findings lead to the development and 
implementation of the COPD Community Linkage service, which aims to strengthen community-based care 
and reduce unplanned hospital admissions.  The service features a unique partnership between the WA Health 
Department and two Divisions of General Practice to achieve an integrated community based service that 
covers a region with resident population of 617,783 people. The model consists of four main elements: 
¾ Community based multidisciplinary assessment and review away from the tertiary setting and delivered at 
local sites throughout the community.   
¾ Providing access to Pulmonary Rehabilitation within the community setting. 
¾ Client surveillance and case management support through improved coordination of services to patients 
through facilitating linkages with GPs and specialist services. 
¾ Fostering self-management through the provision of self-management programs and facilitating patient 
support groups. 
An evaluation of the service assessed the improved outcomes for patients with COPD in terms of quality of 
service and continuity of disease management provided through the specialised community based COPD 
linkage service.  The evaluation has demonstrated: 
- The development of a comprehensive electronic database designed to meet the specialised 
requirements of people with COPD being managed in the community and able to transfer data into 
GP medical software. 
- Patient empowerment fostered through education, self-management and patient support groups 
shown to support people to better manage their condition and prevent hospital re-admission.  
- The development of best practice protocols designed to use in the community and primary health 
setting. 
- The satisfaction levels and opinions of referrers such as GPs, inpatient hospital clinicians and nursing 
staff demonstrating the services ability to meet patient needs within the community, while improving 
communication between the specialist staff and GPs.  
- A reduction in the frequency of readmission and length of stay in hospital for people accessing the 
COPD Community Linkage Service.  
 
1140AM 
Evaluating a statewide chronic care program – was there an improvement? 
Presenter:  Ms Poppy Doungkamol Sindhusake, Centre for Health Services Research at 
Westmead [for WN(Bill) Schofield, Deputy Director, Centre Health Services 
Research, Western Sydney Area Health Service & School Population Health, 
Uni of Sydney NSW] 
Authors: Schofield WN, Sindhusake D, Rubin GL, Campbell D, Guo Y, Lai YY Centre for Health 
Services Research at Westmead NSW 
 
Australia has recently initiated programs to stem the rapid increase in the number of Australians suffering 
chronic illness. In NSW a Chronic Care Program was established in 2000 and Phase 2 of this program 
commenced in 2003 with an annual budget of $15 million. A key activity of this phase was the Chronic Care 
Collaborative (CCC) which involved 22 teams in 18 Area Health Services from April to November 2004. 
CCC aimed to improve the management and care of patients with HF and COPD using a Breakthrough Series. 
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We were contracted to evaluate this intervention using audit data sent by teams; a survey conducted by our 
Centre; questionnaires completed by team members at learning sessions; a monthly self assessment scale 
completed by teams; NSW hospital inpatients data for 2003 and 2004 and the recorded and transcribed 
qualitative data from 6 focus group meetings and 26 semi-structured interviews with team members. Analysis 
of the NSW hospital inpatients data has shown that percentages of heart failure(HF) and chronic obstructive 
pulmonary disease(COPD) admissions were significantly less in November to December 2004 than in the 
same time last year (p<0.05). Our findings support the hypothesis that the CCC has improved the skills of 
team members to successfully introduce clinical practice improvements. The care of HF and COPD patients 
has likely improved as a consequence of this. 
 
 
 
1200PM 
Multicultural Information on Depression online (MIDonline): Development and evaluation of a 
multilingual depression information website 
Presenter:  Dr Litza Kiropoulos, Research Officer, Dept General Practice Monash Uni VIC 
 
The current presentation will discuss the current development and evaluation of a depression information 
internet resource targeted at people of cultural and linguistically diverse (CALD) backgrounds. The specific 
aims of the study are to: 1) develop and evaluate the depression-specific internet resource named 
“Multicultural Information on Depression” (MIDonline) which is designed to assist in pathways to care and 
which is designed for consumers, carers and health professionals; 2) to examine and improve depression 
literacy and decrease mental health related stigma in mid to older aged Greek and Italian-born people (45 
years and older); 3) and to examine the relationships between depression and cognitive, personality and social 
factors in Greek and Italian-born people. 
 
 
 
1200PM 
Are chronic heart failure management programs optimising patient outcomes? 
Presenter: Ms Andrea Driscoll, PhD Candidate, NHMRC Scholar, Deakin Uni VIC 
Authors:  Driscoll A,1 Worrall-Carter L,1 Stewart S.2  
Deakin Uni, Melbourne 1 Uni of SA, Adelaide & Uni of Queensland, Queensland. 2   
 
Background: Chronic heart failure management programs (CHF-MPs) are part of standard care in Australia for 
patients with Chronic Heart Failure (CHF). Both national and international expert guidelines advocate their 
implementation and meta-analyses has proved their overall efficacy. However, heterogeneity between 
programs is prolific which may result in variable patient outcomes.  
Method: Fifty six post-discharge CHF-MPs were identified from a systematic review of the health care system 
and 46 CHF-MP’s responded.  Of the 56 programs, three had ceased operating and eleven declined to 
participate.  A thirty three-item questionnaire was sent to 46 CHF-MP’s and all responded (n = 46). The 
questionnaire examined CHF-MP’s characteristics and interventions used within each program.  
Results: Survey revealed a disproportion distribution of CHF-MPs nationally: Vic had 15 programs, NSW had 
23, Qld, and SA had 3 programs each and WA had 2 programs. Overall, 8000 post-discharge CHF pts 
(median: 126; IQR: 26-260) were managed via CHF-MPs. Approximately 40,000 CHF pts are discharged from 
metropolitan institutions nationally, this represents only 22% of the potential caseload for these cost-effective 
CHF-MPs. Majority of programs were located within an acute hospital (52%) and 36% were community based 
of which all were associated with a hospital. Heterogeneity of CHF-MPs in models of care was evident with 
75% of programs implementing CHF outpatient clinics and 77% conducted home visits. A hybrid approach to 
CHF-MPs was common with many programs comprising of an outpatient clinic, home visits and inpatient visits. 
Follow up calls were utilised in 90% of programs but were an adjunct to the predominant model of care. 
Conclusion: Many major hospitals are linked with a CHF-MP and the implementation of these programs into 
the community sector is expanding rapidly. However, heterogeneity between programs exists especially in 
terms of model of care applied. Variability between programs may translate into suboptimal care for patients 
with CHF. National benchmarks for these programs must be developed to ensure optimisation of patient 
outcomes and evidence-based national standards in health care delivery.   
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1200PM 
National online disease management survey 
Presenter:  Mr Bobby Amin, Research Assistant, Dept Epidemiology and Preventive 
Medicine, Monash Uni VIC 
 
In early 2006 a national online survey of disease management initiatives was undertaken. The survey sought to 
gather information related to the existence and use of disease management services across Australian health 
care settings. Participants were asked to report on the following aspects of their disease management service: 
size and setting, target condition, utilisation of risk screens, model components, staffing levels, funding sources 
and outcomes measured. Disease management is provided in a range of healthcare settings from hospitals to 
community settings to health funds. The results demonstrate there are a range of service components used in 
disease management models of care with the majority being telephone or home based and primarily facilitated 
by nurses. The challenge now for Australian disease management is to continually demonstrate and report 
quality and effectiveness in order to successfully embed successful services in the healthcare system. 
 
1330 
Selective outcomes from a respiratory coordinated care program (RCCP) providing community 
based interventions for COPD patients for 2005 
Presenter:  Mr Nick Spiliopoulos, NUM, The Respiratory Coordinated Care Program, St 
George Hospital NSW 
Authors: Spiliopoulos N, Donoghue J, Clark E, Dunford M, St George Hospital 
 
In 1995 the Respiratory Coordinated Care Program (RCCP) at St George Hospital, was commenced to assist 
people living within the hospital’s catchment area who had COPD (DRG groupings E65A/E65B). The aim of 
the program was to reduce hospital admission rates, readmission rates, hospital length of stay (LOS) and 
optimise participants’ respiratory condition to help them live as independently as possible at home. The model 
of care encompasses a collaborative approach that utilises a comprehensive network of respiratory physicians, 
nurses, physiotherapists, social workers, community services personnel and general practitioners who 
collaborate with the six RCCP team members (4.0 FTE equivalent) undertaking home visits (i.e. occasions of 
service).  Additional components of RCCP include a Pulmonary Rehabilitation program and an early discharge 
service. 
The 2005 outcomes show a monthly average of 180 long-term RCCP participants had a total of 69 hospital 
admissions, accounting for a total of 356 bed days. The mean length of stay (LOS) was, on average, two days, 
(5.16 days, a 28.3 % reduction) shorter than the national DRG average of 7.2, saving a total of 141 bed days.  
The average number of RCCP hospital admissions per patient was 0.38 compared to the 2005 national DRG 
average of 1.31 hospital admissions per patient for the DRG E65 family. The hospital readmission rate for 
RCCP long term participants was 4.4%. 
In addition, our early discharge program had 89 participants in 2005. The mean length of stay (LOS) was 3.5 
days compared to the national DRG average of 7.2 days, saving a total of 329 bed days. The RCCP early 
discharge hospital readmission rate was 0 %. 
The total cost of providing this combined service in 2005 was $269,000. The average annual cost of 
maintaining each participant on the RCCP in 2005 was approximately a thousand dollars. This estimation does 
not take into account the cost of 470 saved bed days, nor the cost saving related to the reduced admission 
rate differential between the RCCP average DRG admission rate (0.38) and the national average DRG 
admission rate (1.31) 
The RCCP cost effectively decreases the length of hospital stay and prevents readmission. The use of an 
established specialised home care service and experienced respiratory staff in conjunction with an early 
discharge program reduces the cost and increases acceptance by medical staff and patients.  
 
1330 
The emergence of Tai Chi as an acceptable and effective exercise approach in improving health 
outcomes for older people 
Presenter:  A/Prof Keith Hill, Director, Preventive and Public Health Division, National 
Ageing Research Institute VIC 
 
Tai Chi is gaining popularity as a form of exercise for older people in Australia.  While there is growing 
interest in this type of exercise, there remains considerable lack of understanding about the different types of 
Tai Chi, and that these different types of Tai Chi may be associated with different health benefits, similar to 
the differing health benefits associated with other forms of exercise, such as walking and strength training.  
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This presentation will review the substantial growth of research evidence from randomised trials 
demonstrating that Tai Chi can be used to achieve a range of health for older people.  Identified benefits 
include improved physical outcomes such as improved balance, strength, and function, and reduced falls, as 
well as a range of psychological benefits including reduced fear of falling, reduced anxiety and depression, and 
even improved sleep.   Health benefits have been reported in healthy older samples, as well as older people 
with a range of health problems, including osteo- and rheumatoid arthritis, vestibular dysfunction, people with 
chronic stable cardiac failure, and those with borderline hypertension.  The presentation will also briefly 
discuss a large randomised currently underway in Melbourne, led by Dr Lesley Day at the Monash University 
Accident Research Centre.  This trial is evaluating the effectiveness of Tai Chi for Arthritis in preventing onset 
of disability among older women in retirement villages.    
 
1330 
Internet based approaches to behaviour change in disease prevention and management 
Presenter:  Dr Michael McCoy, Managing Director, Fitness2Live, VIC 
 
The development of scalable, software-driven, online interactive health services represent the potential to 
provide wellbeing and diseases prevention and management services direct to the general community at low 
intervention cost. The challenges are considerable: quality of service, capacity to provide personal information, 
cost of service development and level of internet access within the community, to name a few. 
In July 2003, to coincide with a promotional campaign supporting the importance of physical activity in the 
prevention and management of type 2 diabetes, fitness2live developed and launched Diabetes Australia 
(Victoria)'s 'Online Weight Loss for Diabetes Prevention' program. Participation in the program was voluntary 
and open to the general community.  
808 people (609 female, 199 male, average age: 42.3 years, age range: 16 – 80 years) registered to participate 
in the trial, which was promoted on local radio news and a radio fitness and nutrition talk-back program. The 
website supporting the online trial was available for four months, although the program was of ten weeks 
duration. 
Repeat self-administered usage of an online health risk appraisal (HRA) which formed part of the service 
showed that within ten weeks or less of beginning participation in the program, just under half (49.5%) of 
respondents to a voluntary survey reported an average weight loss of 3.8kg, with a maximum recorded 
individual weight loss of 30kg.  
While 46% of respondents recorded either high or very high risk of illness associated with their HRA score at 
the beginning of the trial, the prevalence of this level of risk had dropped to 33% of respondents by the trial's 
completion. 
Participation data from this trial has been published in Health Promotion International.  
Conclusion: Fitness2live's online health and wellbeing service was quickly adopted within an open community 
setting amongst people at risk of type 2 diabetes. Half of program participants achieved weight loss and 
behaviour change within the trial period, a success rate which rivals more expensive face-to-face disease 
management interventions. 
 
1350 
Keeping track of diabetes – measuring outcomes of a pilot diabetes disease management 
program in a private health insurance population 
Presenter:  Ms Virginia Hagger, Director Education, International Diabetes Institute & Ms 
Julie Andrews, Manager, Health Development Unit, Medibank Private VIC 
Authors:  Hagger V1, Shaw J1, .Andrews J2, Bradshaw S2 
1International Diabetes Institute  2Medibank Private 
 
The ‘On Track’ Program was a 12-month diabetes management pilot, offered to 15,500 Medibank Private 
members based on claims for blood glucose monitors. The program aimed to increase screening rates for 
complications and achievement of treatment targets amongst participants. The intervention, provided by 
International Diabetes Institute (IDI), comprised mailed reminders of diabetes checks and questionnaires at 
baseline, 6 and 12 months to collect test results from their GP and self-reported health and lifestyle 
information. 
The initial 485 members (3%) who enrolled using an opt-in methodology received reports with individualised 
feedback on test results and diabetes information. Participants were advised to seek medical advice for 
management of risk factors when results were outside the target range. The 12-month pilot was completed by 
295 participants, half of whom were male. 
The profile of participants compared to AusDiab showed that participants had lower complication rates and 
better level of control and diabetes management, but over a third still had poor glucose control, high blood 
  16 
pressure and were substantially overweight. The opt-in enrolment process may have contributed to profile 
differences, producing a self-selected group more motivated and interested in their health care. 
Despite this and other methodological limitations such as lack of a control group, results from participant 
surveys and assessment reports showed statistically significant improvements in diabetes control and CVD risk 
factors during the program accompanied by increased numbers meeting lipid treatment targets. Improvements 
were greatest in participants in the highest risk categories at baseline. Frequency of diabetes checks also 
improved. The number of respondents who had not had foot checks decreased compared to baseline, with 
more than half performed following survey invitations or reminders sent out as part of the program. 
The low-intensity mail-based format was well liked with the anonymity perhaps explaining the high proportion 
of male participants. Sixty percent of respondents thought information from nurse educators was very useful 
whilst 80% discussed assessment reports with their doctor and a third indicated increased confidence in 
talking to their doctor. 
The challenges for future disease management programs are to more selectively target potential participants 
and improve recruitment methodologies to enable more rigorous evaluation of the effectiveness of different 
interventions. The heralded changes in Government policy for chronic care management covered by private 
health insurance highlights the importance of increasing participation rates by educating members that 
programs such as this one are integral to managing their disease and improving their quality of life. 
 
1350 
Integrative and complementary approaches to the management of chronic diseases? 
Presenter:  Dr Vicki Kotsirilos, GP and Past Founding President, Australasian Integrative 
Medicine Association (AIMA) VIC 
 
This presentation will discuss some of the evidence for non-pharmacological treatments of chronic diseases. 
These include asthma, depression, headaches and migraine, osteoarthritis, recurrent urinary tract infections, 
benign prostatic hypertrophy, hypertension, irritable bowel syndrome and dementia. With all these conditions, 
lifestyle factors play an important role and can offer substantial relief. Medical practitioners are ideally suited 
to prescribe evidence based complementary medicine (CM) for patients with chronic diseases, particularly 
patients who cannot tolerate or suffer adverse events to pharmaceuticals. 
The use of CM should have certain boundaries. Its use should not be to the exclusion of a clearly indicated, 
safe, effective and superior orthodox therapies. In making choices patients need to be informed about the 
range of reasonable options of orthodox and complementary therapies. Based on clear information patients 
should then be allowed to make their choices as to what treatment they wish to pursue. It is important 
medical practitioners practice within reasonable guidelines and monitor patients closely for any potential side-
effects and clinical response. 
 
1350 
Workplace health and productivity management as a serious economic strategy 
Presenter:  Dr Shirley Musich, Director, Health and Productivity Research Centre, 
Wollongong University, NSW 
 
Health promotion programs targeting individual health behaviors have the potential to improve the health, 
quality-of-life and productivity of a workforce.  Targeted program implementation, including risk reduction, 
disease management and low-risk maintenance strategies, should be based on initial measurements of the 
baseline health status of selected populations.  
The Health Risk Appraisal (HRA) provides one tool for 1) establishing baseline health risk status and 2) the 
tracking of health risk changes over time that may have resulted from participation in health improvement 
programs.  Advanced versions of the HRA have incorporated self-reported work impairment (presenteeism) 
metrics that can be linked to health risks and overall health status.  Measuring the impact of health outcomes 
(health status or medical conditions) on working to the best of one’s ability has added a new dimension to the 
utilization of this tool in population health management strategies.   
Documenting programming that can effectively impact health and productivity (presenteeism and/or 
absenteeism) outcomes along with the establishment of best practices and benchmarks implies adequate up-
front measurement and evaluation designs.  Key outcome metrics should include tracking of participation 
levels and monitoring of changes in the percentage of the population with low-risk status relative to changes in 
selected productivity cost trends over time. If health promotion and prevention strategies are to gain ground 
in corporate or government strategies, we must be able to demonstrate the impact of specifically designed 
programming on health and productivity outcomes. 
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1410 
Diabetes Direct Delivers 
Presenter:  Ms Jacinta Collins, Project Manager, Northern Division of General Practice VIC 
Authors:  Collins J1 Berlowitz D2 
 1Northern Division of General Practice 2The Northern Hospital 
As the sixth leading cause of death in Australia, diabetes is responsible for a significant personal and economic 
burden. At an individual level, diabetes is best mitigated where the patient can be equipped, encouraged and 
empowered to take an active role in managing their condition using a therapeutic regimen. This requires 
constant decision-making and action by the patient in respect of self-monitoring of blood glucose, medication 
intake, nutrition and physical activity. At the same time, patients face the ever-present possibility of developing 
one or more of the short or long term complications of their condition and consequently further reducing 
both their quality of life and life expectancy. 
Funded in 2003/04 via the Hospital Admission Risk Program (HARP), Diabetes Direct is a consortia between 
The Northern Division of General Practice, Northern Health and Plenty Valley and Darebin Community 
Health.  Its' aim is to deliver integrated and holistic diabetes services to residents of Darebin and Whittlesea 
that in turn, will assist to reduce the sustained increases in demand on the Emergency Department and 
Inpatient Units at The Northern Hospital. Based in the community, Diabetes Direct is located within a Medical 
General Practice, and provides interdisciplinary clinical services that include Endocrinology, Dietetics, 
Physiotherapy, Diabetes Nurse Education, Podiatry and Aboriginal Torres Straight Islander (ATSI) Liaison.  
Since March 2004, 165 General Practitioners and other health professionals across acute/primary and 
public/private sectors have requested more than 500 referrals to Diabetes Direct for their patients to receive 
assessment, education and support in the ongoing management of their type 2 diabetes.  Innovative, flexible 
and based on best practice guidelines, the Diabetes Direct model is the future template for HARP diabetes 
ambulatory care programs to be delivered across Northern Health. The presentation will highlight clinical 
improvements in 181 Culturally And Linguistically Diverse (CALD) patients who attended for a minimum of 12 
months from March 2004 - March 2006. Results include HbA1C admission mean of (SD) 8.5% (1.93) reducing 
to a 12-month mean (SD) 7.5% (1.23) and the Assessment of Quality of Life questionnaire utility change score 
improving to mean (SD) 0.1251 (0.221). 
In an environment where a range of ambulatory conditions and intervention models have competed for scarce 
health resources, Diabetes Direct has reliably demonstrated that it is effective in improving clinical outcomes 
and Health Related Quality of Life measures for clients who attend the program. The big picture for policy and 
decision makers is that it is possible for Diabetes Direct outcomes to be evaluated and favorably compared to 
other chronic disease management programs.   
 
1410 
The getting around gracefully program 
Presenter:  Mr Robert Webb, Feldenkrais Practitioner, Moreland Community Health 
Service VIC 
 
Getting Grounded Gracefully is a program of 16 lessons which explore movement and balance in sitting, in the 
transition from sitting to standing, in standing, and then becomes an exploration of the possibility of walking 
with ease. Getting Grounded Gracefully is designed to improve a person’s ability to move easily and gracefully 
and, over the course of the program, help older people have more confidence in their balance and in their 
walking. 
In 2003 Getting Grounded Gracefully was the subject of a pilot study undertaken by the National Ageing 
Research Institute, Melbourne, Australia (NARI). Thirty six women aged 65 years and over were recruited 
from a carer’s respite program and the community.  
The presentation will include a discussion of the principals underlying the Feldenkrais Method and, in 
particular, the Getting Grounded Gracefully program. Also results presented will include an exploration of the 
benefits of the program from the viewpoint of the participating women using their diaries as the main data 
source.  Themes that emerged from comments reported in diaries indicate that the women experienced 
improved balance, increased ability to function in everyday activities and improved confidence; for instance in 
walking and moving from sitting to standing.  Improvement in breathing, reduction in pain, and recovery from 
near falls were also reported by some participants.  Productive activities were accomplished with greater ease, 
for example, driving, tasks associated with caring for invalid spouses, and sewing.  Many participants reported a 
greater freedom of movement generally.  Also, quantitative results on a range of outcomes will be presented 
including balance, postural stability and functional mobility tests conducted pre and post the intervention. 
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Finally information about a Randomised Controlled Trial of the Program currently being undertaken by NARI 
will be presented. A version of the program on CD was released to the public in 2005 (see 
www.gettinggroundedgracefully.com.au). 
 
1410 
Future trends in corporate healthcare 
Presenter:  Dr Jonathon Orelowitz, Director, Healthlogix Pty Ltd 
 
Disease management (DM) is a growth industry, but still looking for its identity. By some estimates, the U.S. 
market for DM is from $20-$30 billion in annualised revenue. With estimated DM revenues of $1.2 billion in 
2005, a substantial growth opportunity exists.  
In the USA, sophisticated employers and health plans are looking to work with vendors that can bring an 
integrated approach to care management and Return On Investment (ROI). As such, American companies and 
corporate America are now looking at DM programs as they seek to manage the premiums they pay to health 
insurers. Companies such as Ford, GM, GE etc are focusing on reducing healthcare costs. Health plans play a 
significant role in DM across employers in the US where: 
• 45% of all employers currently offer DM benefits and another 22% intend to offer benefits by 2006. 
• 68% of all employers partner directly with a health plan for program design or implementation  
If employers begin to effectively mandate participation in these programs, we are likely to see substantial 
growth opportunities.  
In Australia, the picture is very different as employers do not pay for health insurance. But, many organization 
and large corporates are now starting to realize the impact of poor health on productivity, absenteeism and 
performance. Here, the number of people with chronic conditions with: 
• Approximately 300,000 Australians  diagnosed with heart failure and another 30,000 new cases 
diagnosed each year 
• Over 800,000 registered cases of diabetes, with 100,000 new cases diagnosed annually. 
• Approximately 2.2 million (12%) people have asthma.  
• About 60% of adults (68% of males and 53% of females) either overweight or obese  
In Australia, employees have historically focused on Occupational Health and Safety, but are now realizing that 
the obese diabetic employee who smokes is costing them more than they previously thought. Many 
companies are now introducing Health and Wellness programs or offering services such as company 
sponsored Health checks, seminars, Fluvax inoculations and even other services like massage and 
aromatherapy. This is a good start as awareness of these health issues takes root. All this is a far cry from 
DM. 
The question now is: Will Australian companies and corporate Australia be willing to invest in DM programs 
in the coming decade as they begin to realize the cost to company of many chronic conditions. 
 
 
 
1430 
Snakes and ladders: the challenges and triumphs of improving diabetes care in Melbourne’s 
West 
Presenter:  Ms Naomi Kubina, Project Officer, WestBay Alliance Newport VIC 
Authors:  Kubina N1, Symington F.M.1, Hamblin S2 and Kennedy L3  
1WestBay Alliance/ Western HARP Consortium; 2,Western Health, Footscray; Department 
of Endocrinology Vic 3WestBay Alliance, Newport, Victoria 
 
A vast body of evidence supports the effectiveness of improving screening rates, monitoring glycaemic control 
and enhancing self-management to delay the long-term complications for diabetes. Yet, available research 
indicates that this does not occur nearly as often as expected.  
The prerequisites for disease management provide a foundation to ensure essential elements of diabetes care 
are provided and hence improve outcomes. Yet developing appropriate systems to support this work can be 
challenging.  Designing solutions that reflect the different roles of agencies across the care continuum can 
seem overwhelming. We need to grapple with the shortfalls of our healthcare system and the partnerships 
needed to support such redesign work.  
Our partnership of acute, community and primary agencies is taking on this challenge by using the work of 
Improving Chronic Illness Care’s Chronic Care Model developed at the MacColl Institute for Healthcare 
Innovation. Adapting this model to an Australian context, we are targeting those at risk of hospitalisation and 
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developing complications through innovative approaches to diabetes care. The model is based on a staged 
approach to ensure agencies are not overwhelmed in the change process.  
Our model for diabetes management ensures all people are risk-screened and fast-tracked through the system 
on the basis of their clinical risk and needs. Identification of urgent and high risk patients has allowed more 
suitable targeting of care. Improvements in regular monitoring of diabetes complications and self-management 
capacity, underpinned by diabetes registers and reminder systems facilitate adherence to best-practice 
guidelines and performance standards. Decision support tools foster proactive care with planned follow-up. 
One such example is a diabetes management calculator that determines frequency of recall based on clinical, 
psycho-social and self-management risk. A comprehensive professional development program for health 
professionals in motivational interviewing and stages of change theory has enhanced the ways in which self-
management support is delivered.  
This paper will reflect on how a disease management approach has enabled clients to be proactively 
monitored and supported in their self-management and how this systems redesign work has facilitated 
comprehensive changes to how agencies plan and deliver services to improve diabetes care. 
 
1430 
Integrative medical approaches to primary and secondary prevention of cardiac disease 
Presenter:  Dr Gary Deed, Medical Practitioner, Integrative Medicine Your Health, 
Brisbane, QLD 
 
Cardiovascular diseases still claim 1 life in every 10 minutes in Australia. Research supports the use of simple 
cost-effective interventions to assist primary and secondary prevention of morbidity and mortality. An outline 
will be discussed of the evidence to support an integrative process involving  
• Exercise  
• Diet focussing on “Mediterranean” approaches to food selection    
• Selection of targeted patient groups  
• Tailored nutritional approaches involving fatty acids, and other nutritional supplementation  
with a baseline of evidence-based medical therapy.   
Implementation using team approaches utilising allied health workers such as exercise physiologists and  
dieticians, and nursing staff combined with use of computerised clinical tools will be discussed.  
 
 
1430 
Evidence based care and prioritisation of people waiting for elective hip and knee replacement 
surgery: the new Victorian management and prioritisation system 
Presenter:  Ms Catherine Jones, Centre for Rheumatic Diseases, Royal Melbourne Hospital, 
University of Melbourne 
Authors: Osborne R1, Roberts M2, Graves S1, Jones C1, Chubb P1, Brand C3,1, de Steiger R4, Wicks I1 
for the OWL Project team. 
1Centre for Rheumatic Diseases, Royal Melbourne Hospital, The University of Melbourne. 
2 Statewide Elective Surgery Program, Victorian Department of Human Services 
3 Clinical Epidemiology and Health Services Research Unit, The Royal Melbourne Hospital. 
4 Department of Orthopaedics, Royal Melbourne Hospital  
 
Improving quality of care and rational, equitable allocation of resources is central to current health reform in 
local and international settings. The Victorian Department of Human Services funded a University of 
Melbourne/Melbourne Health partnership to develop a new system to manage orthopaedic waiting lists and 
provide a model for elective surgery reform for Victorian public hospitals. 
A prioritisation system for people requiring joint replacement surgery (JRS) and a service model of care to 
ensure patients received effective care whilst waiting for surgery were developed. 
A Management and Prioritisation Tool (MAPT) was developed with prioritisation domains derived through 8 
workshops and extensive clinical consolation. Domains were pain, activity limitations, psychosocial wellbeing, 
economic impact and deterioration. 11 items survived rigorous clinimetric and statistical item selection. Items 
were weighted by orthopaedic surgeons (N=96) using Discrete Choice Experiments. Extensive validation 
included co-administration with standardised questionnaires (960 patients) and verification of patient MAPT 
scores through clinical interview. 
The MAPT finely ranks patients requiring JRS on a 100 point scale, clearly differentiating levels of severity even 
at the severe to very severe end of the scale. It also has the potential to improve referral from GPs, prioritise 
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outpatient appointments and support evidence-based resource allocation. Alongside this, a musculoskeletal 
coordinator service model promotes readiness for surgery and improved GP-Hospital communication. 
An evidence-based, valid and user friendly prioritisation tool has been developed. The model of care within 
which it can be applied has been defined. The MAPT and associated service model will significantly impact on 
elective surgery reform in Victoria. 
 
1530 
Chronic Disease Management in the Australian Community Setting: Evaluation Using Cross- 
Jurisdictional Record Linkage 
Presenter:  Dr David Preen, Research Felloe, School of Population Health, Uni of WA, WA 
 
In Australia, chronic diseases account for some 70% of the total disease burden and are a national priority 
area, with many initiatives endeavouring to improve outcomes. Also, there is growing evidence that timely 
provision of ambulatory medical care maintains population health and avoids unnecessary hospital use. While 
continuity-of-care is a hallmark of successful ambulatory care, the evidence in support of its importance in 
reducing adverse events for chronic disease is mixed.
 
Results have also been inconsistent as to whether site or 
clinician continuity is the more important.  
One method of evaluating the role of primary care in chronic disease management, on a population scale, is 
that of medical record linkage.  Commonwealth and State policy makers, and health planners have increasingly 
recognised the benefits of data linkage. Its application to the development and evaluation of health services 
delivery, health outcomes and health policy is now a top priority in the National Health Information 
Development Plan and is included as a key priority capability area in the strategic roadmap of the National 
Collaborative Research Infrastructure Strategy. Record linkage maximises the use of available data and makes 
it feasible to follow-up entire populations both time- and cost-efficiently. It enables retrospective studies to be 
conducted many years after exposure to an agent, or policy, and minimises loss to follow-up and reliance on 
self-reported data.  
The WA Data Linkage System, established in 1995, is unique in Australia and constitutes a powerful source for 
conducting health services and outcomes research on an entire population within an Australian setting. It 
combines seven core WA health datasets linkable to >30 external research databases. Formal links have also 
been established with Commonwealth Medicare and PBS data.  
Recently, work has commenced on applying cross-jurisdictional record linkage to study primary care 
management of various chronic diseases. This presentation will outline the work performed to date, and 
future plans to investigate chronic disease areas of public health significance.   
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The COACH Program: an evidence based, telephone delivered, disease management program 
proven to reduce hospital admissions in patients with coronary heart disease 
Presenter:  Dr Margarite Vale, Director, COACH Program, Dept Cardiology and Uni of 
Melbourne Dept Medicine, St Vincents Hospital VIC 
Authors: Vale M, Jelinek M, Best J.  
 
Background: Telephone Coaching Program (TCP) was developed to bridge the gap between evidence-based 
medicine and usual care.  TCP is a training program for patients with CHD whereby a health professional 
coach trains patients to vigorously pursue the target levels for their particular coronary risk factors while 
working in partnership with their own doctor(s).  The coach uses the telephone and mail outs to provide 
regular coaching sessions to patients after discharge from hospital.  At each session the coach assesses 
patients’ knowledge, educates where appropriate, empowers the patient, sets treatment goals for the patient 
and monitors the achievement of these goals.  Coaching trains patients to ‘drive’ the process of achieving and 
maintaining the target levels for their risk factors. 
 
The Evidence: A pilot RCT of coaching at St. Vincent’s Hospital where the coach never met the patients face 
to face demonstrated that coached patients achieved a total cholesterol(TC) of 5.00 mmol/L compared with 
5.5 mmol/L in usual care.1  A subsequent six-centred RCT where the coaches recruited patients as in-patients 
confirmed that coaching could reduce the TC more than usual care and also showed that coached patients 
achieved a lower LDL-C, blood pressure, body weight, dietary intake of total and saturated fat, dietary 
cholesterol, higher fibre intake, less anxiety, less chest pain, less dyspnoea at follow-up.2  At 6 month follow-
up, more coached patients were walking and more reported better health, mood and fitness.2  A 4-year 
follow-up of the 792 patients in the multi-centre COACH study2 was recently performed by the Victorian 
DHS to determine the impact of TCP on deaths and subsequent hospital utilisation. 3  The survival of both 
coached and non-coached patients was 92% 4 years after randomisation.  There was a 15% reduction in 
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cardiac bed-days, 16% reduction in hospital admissions for any cause, and a 20% reduction in bed-days for any 
cause in the coached group (P<0.001 for all).3  TCP is currently operating in Victoria from 4 teaching hospitals 
and one division of general practice and has recently expanded into South Australia and Western Australia. 
Currently over 3,000 patients are enrolled in Victoria alone.  Results show improvement in the number of 
patients achieving their risk factor targets and taking recommended medications.  With further government 
support, TCP will be rolled out throughout Australia 
  1Vale MJ et al.  J Clin Epidemiol  2002; 55: 245-252. 
2Vale MJ et al.  Arch Intern Med 2003; 163: 2775-83. 
3Vale MJ et al.  Circulation  2004; 110: Suppl: III-801 (abstract). 
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0910 
Closer to Home – Shifting Care in England 
Presenter:  Mr Alan Doran, Director General, Departmental Management, Department of 
Health, UK 
 
The NHS faces new challenges as its population ages and needs stem more from coping with fluctuating, long 
term conditions rather than a pattern of one off acute episodes. The new strategy therefore looks to extend 
the programme of health reform to the broad range of services provided outside acute hospitals. The aim is to 
re-align the care system so that it better supports individuals to retain independence and promote their own 
well-being. 
 
Those who use services will be given more control, care will be shifted to local communities, inequalities in 
provision will be tackled and much more emphasis given to integrated care for those with long term 
conditions. 
 
 
0955 
Chronic Disease Prevention and Treatment – cost benefit model systems to assist with priority 
setting 
Presenter:  Prof Jim Butler, Australian Centre for Economic Research on Health, Australian 
National Uni, ACT 
 
Economic evaluations of health-affecting interventions and policies have expanded enormously in the past few 
decades.  These evaluations are often used as an input into decision-making about public funding of health 
programs and other projects, and priority setting for resource allocation purposes.  But is the technique up to 
the task?  What are the limitations of economic evaluation in priority setting?  What are the important issues 
that need to be addressed by future research? 
 
1100 
Auditing Cardiac Rehabilitation Programs – Pitfalls and Pluses 
Presenter:  Ms Narelle Wilson, Royal Perth Hospital WA 
Authors:  Wilson N, Smith J, Vulin M, Maiorana A, Mackenzie E, Oliver K. Royal Perth Hospital 
 
Conducting an audit of Cardiac Rehabilitation (CR) programs can provide a valuable insight into the patient 
group the program aims to service.  It enables development of benchmark data from which the impact of any 
future program changes and developments can be measured.  A recent telephone follow up audit conducted at 
Royal Perth Hospital (RPH) of Ischaemic Heart Disease patients discharged from the coronary care 
unit/cardiology ward 3 months prior to the audit date, enabled the Cardiac Rehabilitation Coordinator (CRC) 
to  
• identify the uptake of services post discharge,  
• examine the outcomes for patients who were involved in CR services 
• compare outcomes for those who utilised CR services with those patients who did not utilise CR services  
• compare outcomes for both groups against National Heart Foundation guidelines 
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The challenge of developing CR programs to meet the needs of all patient groups requiring the service can be 
facilitated by processes which give the program coordinators a better understanding of the target group.   
Choices that are made and implemented to improve CR services and the impact these changes have on the 
target group can be re-evaluated at a later date and compared against the benchmark data originally obtained.   
Results of the RPH telephone follow up audit conducted in 2005 will be presented.  Pitfalls and pluses of the 
auditing process will also be discussed. 
 
1100 
Disease State Management Programs in Community Pharmacy - Diabetes 
Presenter:  Mr Lance Emerson, Director Programs & Professional Development, The 
Pharmacy Guild of Australia and Mr Brendan O’Loughlin, St Ives Pharmacy, 
Sydney NSW 
 
 
On average, each person visits a community pharmacy 14 times each year in Australia. This makes community 
pharmacies one of the most visited and accessible health care providers, with around 4,900 locations 
throughout metropolitan, regional and remote areas.  
 
Whilst the role of community pharmacies has been focused largely on ensuring quality use of medicines, 
increasingly in Australia and internationally their role is expanding to include early detection of chronic 
conditions and subsequent referral of patients to their usual General Practitioner for diagnosis. The patient 
can consult a pharmacist without an appointment, with minimal waiting times. Visits to a community pharmacy 
therefore offer an excellent opportunity to undertake screening, education and referral of individuals at risk of 
diabetes. 
 
This presentation will highlight trends in the pharmacist’s role in early identification and assistance in self 
management of diabetes, and provide evidence from a number of recent large scale clinical trials in this area. It 
will also provide a “coal -face” example of the role of community pharmacy in assisting people with diabetes 
self manage their condition.  
 
 
 
1120 
Are chronic disease self management programs generalisable across conditions? 
Presenter:  Ms Virginia Hagger, Director Education, International Diabetes Institute VIC 
Authors:  Hagger V1 ,Graham M2 ,Keleher H3, Barr L1 , Shaw J1.  
1International Diabetes Institute, Caulfield, VIC, 2Deakin Uni, Burwood, VIC, 3Monash Uni 
Frankston, VIC. 
 
Self management education (SME) promotes the adoption of skills, behaviours and coping strategies to enable 
patients to actively participate in their health care and decision-making and to maintain health and wellbeing. 
Studies of SME for people with chronic conditions have demonstrated improvements in health status, 
symptoms, and hospitalisation rates1,2. However, evidence is lacking about whether a generic model is more or 
less effective than a program developed for a specific disease. Another unanswered question is to what extent 
SME interventions address health inequalities. An important consideration for the transferability of SME 
interventions is social determinants of health and the need to target disadvantaged groups who are more 
frequently affected by chronic disease3. 
We conducted a systematic review according to accepted guidelines4 to investigate (i) the effectiveness of SME 
to improve the health outcomes in people with different chronic diseases, and (ii) the generalisability of a 
generic model to different conditions, to inform policy development and practice decisions.  
A comprehensive search strategy was developed and Medline, PsychInfo, CINAHL and EMBASE, Cochrane, 
DARE and AustHealth electronic databases were searched. Publications between 1995 and 2005 that assessed 
the effectiveness of SEM in people (≥18 years) with diabetes, asthma and coronary artery disease (CAD) were 
included. Studies targeting indigenous and culturally diverse peoples and disadvantaged populations were also 
included. Studies needed to have a control group and meet minimum pre-defined quality criteria. In order for 
a paper to be included, the SME program contained at least two of the following components5: 
1. Information about the condition and treatment options 
2. problem-solving 
3. goal setting or action plans  
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4. Behavioural support – eg. physical activity, dietary change, coping skills for managing the emotional 
demands of living with a chronic illness 
Analysis of studies considered: theoretical basis, background of providers, program format and intensity, 
duration of follow-up, characteristics of participants and generalisability of outcomes. Due to heterogeneity of 
interventions and outcome variables, a narrative synthesis was employed to address the research questions. 
There were fewer studies of diabetes and CAD SME programs that met the inclusion criteria than for asthma, 
and overall, few targeted disadvantaged or culturally diverse populations. Participation favoured better 
educated, Caucasian, females with lower morbidity. Final results and conclusions regarding effectiveness and 
generalisability will be reported.  
This research/project was funded by the State of Victoria through its Department of Human Services (DHS).  
The views and conclusions are those of the authors and do not  necessarily represent those of DHS. 
 
1130 
Success of Disease Management Programs In Community Pharmacy - Asthma 
Presenter:  Prof Carol Armour, Pharmacy Faculty, University of Sydney and community 
pharmacy specialist in Guild Asthma Program NSW 
 
Background: Many pharmacy-based programs have been developed which have shown improved asthma care.  
However, to be sustainable these programs should follow national best practice guidelines and take into 
account the needs of local practitioners.  
Aims: To develop a national clinical service (the Pharmacy Asthma Care Program – PACP) based on Australian 
National Clinical Guidelines, taking into account practitioners’ needs and involving patients in goal-setting to 
improve their management of asthma .  To  evaluate the service. 
Methods: A multi-site, randomised control-versus-intervention, repeated measures design was implemented in 
50 pharmacies (24 control and 26 intervention) across three states in Australia. The PACP service for 
intervention patients involved a cycle of assessment, goal setting and monitoring over six months and followed 
the National Asthma Council 6-step Asthma Management plan.  Over 3-4 visits, asthma severity, spirometry, 
inhaler technique, medications and lifestyle issues were reviewed and interventions delivered. Patients were 
referred to their physician for an action plan or other issues when required. Control patients were assessed 
for asthma severity and spirometry at 0 and 6 months, and received no interventions beyond standard patient 
care. Economic, clinical, and humanistic outcomes were used to evaluate the service.  
Results: A total of 351 patients (165 intervention and 186 control) completed the study and of these, 80% 
were referred to their physician at least once. On average, patients set three goals for themselves (the 
majority related to medication) and only 9% of patients reported not achieving their goals. There were 
significant (p<0.05) changes over time in the intervention patients compared to control patients for several 
parameters.  In the intervention group, there was a decrease in the proportion of those with severe asthma 
(88% to 53%); an increase in those classified as adherent to preventer medications (54% to 71%); a decrease in 
salbutamol use; improved quality of life, asthma knowledge and perceived asthma control scores; an increase 
in those having correct inhaler technique (24% to 73%) and an asthma action plan (23% to 64%). The PACP 
was highly cost-effective when compared to other funded programs in Australia.  
Conclusion: The National PACP implemented by community pharmacists has changed the way patients are 
managed in Pharmacy with significant clinical and humanistic benefits for asthma patients, and economic 
benefits for the health care system. 
Acknowledgements: The Pharmacists who were so enthusiastic and supportive. This project was funded by 
the Australian Government Department of Health and Ageing as part of the Third Community Pharmacy 
Agreement. 
 
 
1140 
Who benefits most from participating in chronic disease management programs? 
Presenter:  Ms Sandra Nolte, Collaborative Institute Research, Consulting and Learning in 
Evaluation, RMIT Uni & AFV Centre for Rheumatic Diseases, Uni of Melbourne 
VIC 
Authors:  Nolte S1,2, Elsworth G1, Springer A2, Sinclair A3 ,Osborne R2 
1 Collaborative Institute Research, Consulting and Learning in Evaluation, RMIT Uni 
2 AFV Centre for Rheumatic Diseases, Uni of Melbourne 3 School of Exercise and Nutrition 
Sciences, Deakin Uni 
 
Objectives: To quantify the benefits that people receive from participating in self-management courses and 
identify subgroups that benefit most. 
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Research Design: People with a wide range of chronic conditions attending self-management courses (N=1,341 
individuals) were administered the generic Health Education Impact Questionnaire (HEI-Q). Data were 
collected before the first session (baseline) and at the end of courses (follow-up) resulting in 842 complete 
responses. The median (interquartile range) age was 64 (54 to 73) years and most participants were female 
(75%). Outcomes were categorized as Substantial improvement (Effect Size, ES ≥ 0.5), Minimal/No change (ES 
-0.49 to 0.49) and Substantial decline (ES ≤ -0.5). 
Results: On average, one third of participants reported substantial benefits after attending a self-management 
course. Proportions of participants reporting substantial benefits ranged from 49% in Skill and technique 
acquisition to 27% in Health service navigation. Stratification by gender, age and education showed that 
younger participants were more likely to benefit, particularly young women. No further subgroup differences 
were observed. 
Conclusions: Given that the health of people with chronic diseases tends to decline, this evaluation is 
reassuring in that about one third of participants coming from a wide range of backgrounds receive substantial 
improvements in their self-management skills. 
 
1200 
Smoking Cessation - Pharmacy 
Presenter:  Ms Jenny Bergin, Chief Pharmacist, The Pharmacy Guild of Australia and 
community pharmacist specialist smoking cessation programs NSW 
 
The Pharmacy Guild of Australia conducted the Quit Smoking Project to implement an effective quit smoking 
management program in community pharmacy. The Guild received funding from the Australian Government 
Department of Health and Ageing as part of the Third Community Pharmacy Agreement, in recognition of the 
important role pharmacies play in the Nicotine Replacement Therapy (NRT) category.   
The aim of the project was to: 
 Demonstrate an increase in the number of consumers undertaking smoking cessation strategies; 
 Assist those consumers to successfully quit smoking with the use of retail navigation display boards 
(stands) on smoking cessation products, quit plans and referral services, and by providing ongoing advice 
and support; and 
 Evaluate the program’s impact and effectiveness in assisting those consumers to quit smoking. 
A major component of the project was online training on the Quit Smoking Program for pharmacists and 
pharmacy assistants. 
The project compared intervention and control group pharmacies. Key findings showed that customers who 
visited an intervention pharmacy and purchased NRT: 
 Received more useful advice and written information;  
 Were more likely to have been informed of support services; and  
 Were more likely to have completed the NRT program. 
 
 
1200 
Chronic Disease Self Management programs – what is the evidence? 
Presenter:  Ms Sharan Ermel, Research Assistant, Collaborative Health, Education and 
Research Centre (CHERC) Bendigo Health Care Group VIC 
 
Background: In Australia, chronic disease self-management is a burgeoning area of health care due to the 
increasing incidence of chronic disease and the depleting health dollars available to meet the needs of 
Australians1. It is envisaged that to ease the increasing burden of chronic disease, not only on the health care 
system but also on the individual living with chronic disease, self-management activity and commitment must 
increase2.   
Methods: An extensive review of the literature published between 2000 to mid 2005 was undertaken to 
identify and classify the range of chronic disease self-management programs available. The Cochrane, Medline, 
Pre-Medline, CINAHL, Psych Info and Journals@Ovid databases were searched using combinations of 
keywords, in conjunction with additional hand searching of relevant citations and journals. Relevant study 
results were graded according to Levels of Evidence outlined by the National Breast Cancer Centre 
Psychosocial working group, which were based on the earlier framework of the National Health & Medical 
Research Council3 
Results: Over 1500 potential studies were identified through this process. Through adherence to a strict 
inclusion criterion, the number of included papers was reduced to 46 papers detailing 44 studies of chronic 
disease self-management programs or models. The studies identified within this literature review dealt with a 
wide range of self-management interventions. These ranged from programs and interventions developed for, 
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and focused on Individual participants, Specific chronic condition groups, Generic chronic condition groups, 
Culture specific generic condition groups, and Health providers.  
When graded according to the predetermined criteria, 13 papers fulfilled the Level I Evidence requirements; 
21 rated as Level II Evidence; 15 studies rated as Level III Evidence; nine studies fulfilled the Level IVa Evidence 
grade; and one study g fulfilled the Level IVb evidence criteria.  
The identified chronic disease self-management programs could be classified according to the fundamental 
delivery focus of the intervention, and were thus categorised as Self-management education focused group 
interventions, Process or Health Professional focused interventions and Supportive individual interventions 
Conclusions: Based on the Levels of Evidence identified within this review, several recommendations for 
practice were formulated in conjunction with the project advisory committee. These relate to immediate 
implementation of current evidence into practice, the relevance of behaviour change theory to practice, and 
the importance of engagement and support of trained healthcare professionals in the provision of chronic 
disease self-management programs. 
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CLIMATE.tv chronic care without tears 
Presenter:  Prof Gavin Andrews WHO Collaborating Centre, Uni NSW at St Vincents 
Hospital NSW 
 
Unavailable at time of print 
 
  
1400 
Sustaining Chronic Disease Management in remote Aboriginal Communities 
Presenter: A/Prof John Wakerman, Director, Centre for Remote Health, Flinders Uni SA 
 
This paper describes and analyses the critical factors for sustainability of chronic disease programs in remote 
communities. It follows up the successful implementation of a chronic disease management demonstration 
project in four small remote communities in the Top End of the Northern Territory. Our study carried out a 
detailed review of evaluation and other documents associated with the project and supplemented these with 
in depth interviews of key individuals. The paper analyses the factors critical to sustainability in relation to 
context, community engagement, systems flexibility and adaptability, the availability and effect of information 
systems, and finally the human nature of healthcare and policy. 
 
 
1430 
Chronic Disease – A Head on Tackle 
Presenter:  Ms Linda Powell, Assistant Secretary, Chronic Disease and Palliative Care 
Branch, Dept of Health and Ageing, ACT 
 
As our population ages, chronic conditions such arthritis, diabetes, asthma, heart disease and depression will 
affect the lives of more Australians that ever before.  To manage this increasing burden of chronic disease, a 
national strategic policy approach of chronic disease prevention and management has been developed.  
 
This presentation will discuss the National Chronic Disease Strategy and related developments in Australian 
health care. 
 
 
1530 
Canadian Perspectives on disease management 
Presenter:  Dr Peter Sargious, Medical Leader, Chronic Disease Management, Calgary 
Health Region, Canada 
 
Effective population-based strategies for Chronic Disease Management (CDM) require coordination of effort 
between federal, state and local health care authorities.  Given similarities in national and state involvement in  
health services delivery, Australia and Canada may benefit from a shared exploration of future policy in CDM.   
The current developments in Canada will be discussed and invitation to discuss possible areas for  
international collaboration will be raised. 
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1600 
To integrate or not to integrate? Future considerations for chronic disease self management 
programs in the healthcare system 
Presenter:  Ms Joanne Jordan, AFV Centre for Rheumatic Diseases, Uni of Melbourne VIC 
Authors:  Jordan J, 1, 2, Nankervis J 1, Brand C 1, 2, Osborne R 1 
1 AFV Centre for Rheumatic Diseases, Department of Medicine, Royal Melbourne Hospital The 
Uni of Melbourne 2 Clinical Epidemiology and Health Services Evaluation Unit, Royal Melbourne 
Hospital 
 
Objective: The growing burden of chronic disease and the increasing realisation that the current health system is ill 
equipped to deal with this trend has resulted in a health policy shift away from the traditional medical model to a 
more patient centred approach. As such, chronic disease self-management programs (CDSMP) have emerged as a 
potentially important component within this approach. Policy and program trends at the international level 
highlight several critical factors that need to be considered by governments and health care providers alike if 
CDSMP are to be integrated within the broader health system. This study reviewed international and local policy 
literature and sought perspectives from key stakeholders to determine the value and potential for integrating a 
generic group-based CDSMP into the care continuum.  
Method: Prominent self-management policies were identified through a comprehensive literature search. 
Interviews were conducted with policy makers across Australia (n=20), health practitioners (n=20) and consumers 
(n=42) purposefully recruited from metropolitan and rural Victoria, representing key demographics of interest 
including low socioeconomic areas.  
Results: Whilst CDSMP were viewed as having significant potential to be integrated into the health sector it was 
identified that the delivery and content of CDSMP needs to be flexible in order to address the needs of people 
across the disease, age and care continuums. Critical issues to be addressed if CDSMP are to be successfully 
integrated include increasing the profile of self-management; actively engaging and training health practitioners in 
self-management and overcoming system barriers such as lack of integrated referral pathways and networks.  
Discussion: Policy directions at the national level suggest that self-management will be a centrepiece in forthcoming 
chronic disease initiatives. International evidence has highlighted the requirement for a ‘suite’ of programs to 
adequately cater to different stages of the disease continuum, age groups, ethnic backgrounds and socio-
geographical areas. Furthermore engagement with key stakeholders (particularly GPs) is identified as critical to 
ensure the successful integration of CDSMP into the health system.  
Conclusion: Evidence suggests that CDSMP is an important facet in improving care of people with chronic 
conditions. Findings from this study suggest that current infrastructure and policy direction, which have been found 
to be critical factors in facilitating integration of CDSMP into the health sector, are either absent or inadequate in 
Victoria. CDSMPs are currently lacking a sustainable workforce, referral infrastructure and specific policy. Such 
factors need to be addressed before the integration of CDSMP can be considered across the healthcare continuum 
in Victoria.  
 
 
1600 
Improving care for people with osteoarthritis: implementation and evaluation of a multi-
disciplinary osteoarthritis service at Royal Melbourne Hospital 
Presenter:  Dr Caroline Brand, Director Clinical Epidemiology and Health Service 
Evaluation Unit, Melbourne Health VIC 
 
Aim: There are gaps in implementation of patient perceived needs and use of effective interventions for 
chronic conditions, including Osteoarthritis (OA). A multidisciplinary disease management service was 
designed to improve health outcomes of people with OA hip and knee at Melbourne Health (MH).   
Methods: An osteoarthritis service (OAS), based on chronic care principles was designed and implemented at 
Melbourne Health. Structural service redesign included relocating and redefining the role of a physiotherapist 
(BG) as musculoskeletal coordinator (MSK). Service process redesign included; implementation of an evidence 
based clinical pathway for management of OA, supported patient participation in health care with evidence 
based patient information and increased access to education/self management programs, and increased 
communication between healthcare providers using technological solutions and improved acute-community 
partnerships. An advisory group, including professional and consumer stakeholders, oversees the project at 
MH.  A comprehensive program evaluation was undertaken. Process and outcome data will be presented. 
Barriers to patient uptake of recommendations by was documented.  
Results: 54 patients were referred to the OAS between 1/7/05 – 30/3/06. Twenty-three have had 3 month 
reviews. Median waiting time for the service was 15 days. Mean age was 62.2years, 75.9% female and 20% 
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required interpreter support. Multiple comorbidities were documented in >90 %. A post-implementation  
audit identified significant improvement in assessment of emotional status (100% v 0%), Falls risk 
documentation (100% v 7.4%), BMI (100% v 14.8%), referral for physiotherapy ( 38% v 11.1%). The main 
barriers to patient concordance to recommendations for treatment included; access to community services, 
personal preference, cost and overall health condition. Patient and staff satisfaction with the service was high.  
Conclusion: A model of care for high quality ambulatory chronic disease services has been developed that 
meets the Institute of Medicine1 proposed criteria. Early program evaluation suggests the model meets 
previously unmet needs and supports the integration of evidence into practice. Longer-term evaluation is 
required to assess impact on clinical outcomes. Translation of the model into community settings is underway.  
The Commonwealth Government has provided funding to support this project through the Arthritis and 
Musculoskeletal Conditions Improvement program (AMQuIP) 
 
 
1620 
Acceptability, impact and sustainability of the national pilot quality assurance system for self 
management programs 
Presenter:  Ms Joan Nankervis, AFV Centre for Rheumatic Diseases, Uni of Melbourne VIC 
Authors:  Nankervis J, Laidlaw B, Osborne, R 
AFV Centre for Rheumatic Diseases, Department of Medicine, Royal Melbourne Hospital, 
Uni of Melbourne 
 
Chronic condition self-management education and training interventions such as the Stanford Self Management 
Programs (SMP) have the capacity to improve health and quality of life of people with chronic conditions 
whilst reducing the use of health services. This is in line with the outcomes from the recent Council of 
Australian Governments’ meeting where it was indicated that self-management will be a centrepiece in 
forthcoming chronic disease initiatives. 
Aim: report on a large national pilot quality assurance program involving the implementation and of an 
evaluation and quality monitoring system for SMPs including the provision of structured feedback to courses 
course leaders and service providers. 
During 2005/06 the quality assurance program was implemented at 11 diverse organisations across Australia. 
The program involved assisting organisations apply the 42-item Health Education Impact Questionnaire (HEI-
Q), a chronic disease health education outcome measure, and then observe and evaluate the value and impact 
of the quality program.  Interviews with course leaders (n=60) and course participants (n=35) have elicited 
views about course quality and feedback processes. 
Results: The evaluation revealed enablers and barriers to effective implementation and sustainability. Important 
enablers were: 
- Course Leaders and organisations valued an Australia-wide system that provided feedback on course 
quality and the impact on participants.  
- Course Leaders were strongly personally motivated to respond appropriately to HEI-Q course 
report feedback.  
- Completing the questionnaire provided participants with the opportunity to reflect on issues that 
emerge in the course content and reflect on their progression at the end of the SSMP. 
Sustainability issues included: 
- Organisations and course leaders require support, training and flexibility on how to administer and 
manage the use of the HEI-Q.  
- Availability of administrative resources in organisations to support the quality assurance activities. 
- The requirement that course leaders are trained in interpreting HEI-Q course report data.  
A quality improvement framework was developed which identified the actions required of key stakeholders to 
support effective implementation.  
Discussion: With the increasing endorsement of SMP across sectors it is important that course quality is 
known, is acceptable, and is communicated to stakeholders to inform and engender confidence in the SSMP. 
To effectively implement and sustain a quality improvement program for SMP, the processes and tools for 
measuring outcomes need to be responsive, flexible and easily integrated into the organisation and delivery of 
programs.  
 
 
 
 
 
 
  28 
1620 
Evidence Based Therapy in Parkinson Disease 
Presenter:  Prof Meg Morris, Director Allied Health Clinical Research RASP, Prof 
Physiotherapy Uni of Melbourne VIC 
 
Despite Parkinson disease (PD) affecting more than 50,000 older Australians, there have been few controlled 
clinical trials evaluating the effects of movement rehabilitation for people with this chronic and progressive 
condition. As a basis for evidence based practice in physiotherapy and occupational therapy, we conducted a 
randomised controlled clinical trial with 28 people with PD. All were inpatients at a rehabilitation hospital and 
received up to 16 sessions of physiotherapy over a 2 week period. They were randomised to either a group 
that received movement strategy training or a group that received musculoskeletal exercises. Participants 
were measured at admission and at discharge from the hospital as well as three months after discharge. 
Participants in both groups showed improvements is some domains of locomotion and quality of life. In 
addition, those in the movement strategy group showed significant reduction in disability, as quantified by the 
UPDRS total score. Based on the results, guidelines are proposed for designing movement rehabilitation 
programs for people with chronic diseases such as PD. 
 
 
1640 
The Australian experience of telephonic disease management –a new mode of delivery 
Presenter:  Ms Julie Muir, Disease Management Team Leader, McKesson Asia Pacific NSW 
Authors:  Lewis C, Place J, Muir J, McKesson Asia Pacific 
 
This presentation will give an overview of McKesson Asia-Pacific’s telephonic Disease Management 
programme from a Registered Nurse’s perspective. Results from 500 patients over the last 6 months will be 
presented. 
Background: Telephonic Disease Management is an emerging discipline in Australia. McKesson locally is in a 
unique position to provide an insight into this new method of healthcare delivery. This is an Australian 
telephone based programme which originated from a North American model developed by McKesson in the 
United States and has been implemented by McKesson Asia-Pacific. Our nation-wide programme was 
commenced in November 2005 and is conducted by Registered Nurses based across Australia. This 
programme was modified to reflect best practice guidelines and evidence based research from Australian 
professional bodies such as Diabetes Australia, The Royal Australian College of General Practitioners, The 
National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand (CSANZ) and The 
Thoracic Society of Australia and New Zealand (TSANZ). Current programmes include Diabetes, Coronary 
Artery Disease, Heart Failure and Chronic Obstructive Pulmonary Disease. Patients come from both the 
public and private sector. Data to be presented include:  
- Preliminary health outcome results derived from a cohort of 500 members after 6 months participation in 
our programmes. 
- Behavioural illness and lifestyle outcomes across each of the diseases above 
- Registered Nurse’s experience and satisfaction in the delivery of telephonic Disease Management. 
- The call process and sequencing as supported by our specialised software application 
 
1640 
Managing the medications: impact of a clinical pharmacist in a disease management unit 
Presenter:  Ms Robyn Stell, Pharmacist, The Alfred VIC 
Authors:  Stell R1 ,  Dooley MJ 1,2, Bonollo M3,4,5, Fiddes K 3,5  
1Pharmacy Department, The Alfred, Melbourne 2Department of Pharmacy Practice, Victoria 
College of Pharmacy, Monash Uni, Vic 3Disease Management Unit, The Alfred Hospital, 
Melbourne ,Victoria 4Monash Medical School, Monash Unit, Alfred Hospital, Melbourne 
Victoria 5Australian Disease Management Association   
 
Aim: Evaluation of the impact of a Clinical Pharmacist in a Disease Management Unit ( DMU)  
Background:  DMU at Bayside Health Service provides a model of care to patients with chronic and complex 
needs through outpatient clinics, self-management, education and care co-ordination activities. The approach 
to patients medical conditions is proactive. Many of the patients attending  DMU have complex medication 
regimens and have been identified as being at risk of medication misadventure resulting from medication 
management issues, polypharmacy and communication issues between  different care providers.  
Methods: A Pharmacist has been involved with DMU providing clinical expertise, medication review, education 
and community liaison in both a clinic setting and in patients homes. This role complements the work of a 
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DMU team. A grant from Victorian Department of Human Services under the Better Skills, Best Care Project 
was used to investigate opportunities to create and evaluate this new role and career option for hospital 
based Clinical Pharmacists.  
Results : One of the key areas where a Clinical Pharmacist has an impact in a Disease Management Unit is in 
determining an accurate medication list. This involves not only the list of medications the patient is currently 
prescribed but how they are using these medications. In our study an estimated 24% of clients had an accurate 
medication list recorded. Following Pharmacist involvement this was increased to 92%. 
The time clinicians spent determining medications during clinic was reduced by 33% and their perception of 
the accuracy of the medication list increased. 
Review by a Pharmacist identified clinical medication issues and made recommendations in 49% of clinic 
patients and 83% of home visit patients. Patient education and liaison with community providers were other 
key areas of Pharmacist involvement.    
Conclusion : A Clinical Pharmacist working within a Disease Management Unit provides a valuable role in 
identifying medication issues, providing patients with the skills to manage their medications and  providing a 
liaison between various care providers in hospital and in the community.  
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Smoking cessation 2005-2006. Northern Hearts and Lungs Project 
 
Authors: Shields P, Bradley R, Project Managers, The Northern VIC 
 
Northern Hearts and Lungs Project is a Hospital Admission Risk Program (HARP) funded, nurse led 
multidisciplinary team with a Chronic Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease 
(COPD) stream. 
In line with best practice management of COPD, a smoking cessation course was offered to clients who 
continued to smoke.  Complete cessation of smoking is the mainstay of treatment in prevention of 
deterioration of COPD.  Currently, smoking cessation is offered as an outreach service by the Respiratory 
Nurse Consultant.  The program follows the model of care developed by Renee Bittoun, Sydney University, 
Royal Prince Alfred Hospital. 
The program included a number of home visits for 3 months to provide advice and support in smoking 
cessation.  The schedule of visits was as follows.  Two visits per week until the client ceased smoking.  During 
this time, nicotine replacement therapy was commenced according to the Bittoun combination nicotine 
replacement therapy (NRT) algorithm.  NRT was in the form of patches (21mg, 24 hour), 4 mg gum or 4 mg 
lozenges. Patients provided their own nicotine replacement therapy.   
Since October 2005, a total of 18 clients were invited to participate in the smoking cessation program.   Seven 
clients were excluded due to NRT patch allergy (n=1), cardiac event following NRT (n=1), inability to fund 
NRT (n=1 - financial support for NRT is currently being investigated for clients, on a case by case basis), and 
refusal to participate (n=4).  The clients who refused to participate all felt that the program would not benefit 
them.  These clients will be followed-up in three months to determine their readiness to participate in the 
program.  
Eleven patients were included in the smoking cessation program.  Eight (72.7%) stopped smoking.  Of these 
eight, six clients (75%) have not smoked for 3 months.   
In conclusion, this particular smoking cessation program was for smokers who are suffering from chronic 
disease due to their long term smoking habit. Northern Hearts and Lungs have been successful in supporting 
clients to stop smoking and therefore prevent deterioration of the health of clients with moderate to severe 
COPD. 
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Barriers and Enablers to Using Collaborative Methods to Implement a Chronic Disease 
Program for OA in Different Health Settings. 
Authors: Brand C*, Tosti, T*, Moran H^, Downe G#, Ruth D##, Critchley J**, Graves S++, March 
L+, Bellamy N, Bucknall T, Bongetti E, Ibrahim J. 
*Melbourne Health +Royal North Shore Hospital ++Flinders Medical Centre #Dandenong District 
Division of General practice ##Otway Division of General Practice **Goulburn Valley health ^Private 
Rheumatologist Dr H Moran 
 
A multi site clinical collaborative has been undertaken to pilot implement a disease management program for 
people with Osteoarthritis hip and/or knee in different settings including; metropolitan and rural acute care 
and general practice. The pilot took place over a 9 month period between July 2005 and April 2006.  
The program was based on Institute of Medicine principles of chronic disease care and included; 
implementation of evidence into practice for OA management, improving multidisciplinary care provision and 
supporting patient self management.  
Implementation occurred using a PDSA cycle within each site. An OA clinical pathway of care developed in an 
earlier phase of the project formed the basis for sites to implement change. 
Project leadership was provided by one metropolitan hospital (Melbourne Health) and at each site OA 
pathway implementation teams were developed. 
A 6 month evaluation was performed after an initial running in phase of 3 months. The implementation 
process was assessed at each site using program evaluation methods. The overall collaborative group 
effectiveness was evaluated using quantitative and qualitative methods at 6 months. 
This poster will outline the collaborative methods, the main barriers and solutions to barriers associated with 
adoption of the collaborative method for implementation of programs within different settings and by different 
health care providers. 
Contributing sites included; *Melbourne Health +Royal North Shore Hospital ++Flinders Medical Centre 
#Dandenong District Division of General practice ##Otway Division of General Practice **Goulburn Valley 
health ^Private Rheumatologist Dr H Moran 
 
 
Taking Hospital Based Disease Management Clinics to the Community Setting 
 
Authors:  Butler J, Harris J, McMillan E. Disease Management Unit, The Alfred, Bayside Health, 
VIC 
 
In 2003 the Disease Management Unit of Bayside Health, Victoria, commenced clinics in the community setting 
in addition to their hospital outpatient based clinics. The aim of providing the disease management clinics in 
the community instead of the tertiary hospital setting was to provide closer and easier access for the patient 
population and facilitate better linkages to community services in the patients’ local areas. The locations of the 
community clinics include Caulfield Community Health Centre, Inner South Community Health Centre ( both 
South Melbourne and St Kilda campuses) and a General practitioner clinic, the Craigrossie clinic, in Albert 
Park. 
To date over 150 patients have attended the community based clinics. In 2006 a patient survey was conducted 
to evaluate the patients’ experiences with the community based clinics. This poster summarizes the findings. 
 
 
Enhancing Clinical Governance Using Video Conferencing Technology- Linking Two 
Ambulatory Care Units 
 
Authors: Collins N, Warner B. Macarthur Ambulatory Care Service-McArthur Health Service 
Campbelltown, NSW   
 
Camden and Campbelltown Hospitals provides public hospital and community services to a population of over 
250,000 people, covering a geographical area of 3070 square kilometres to the south-west of the Sydney CBD.  
In the late 1990s, the Macarthur Ambulatory Care Service (MACS) was designated to provide total 
substitution of acute care and post-acute care in a location other than a hospital bed.  
MACS comprises a multidisciplinary team consisting of doctors, nurses and allied health professionals, who 
provide a single acute community service, based at the hospitals which are situated 16 kilometres apart.  This 
acute programme cares for up to 180 patients per month. There are up to 26 patients admitted to this 
“virtual” hospital ward at any one time, with an average length of stay of 4.81 days. 
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The introduction of NSW Department of Health Video Conferencing into clinical practice has allowed the 
MACS to further expand its recognised safety and quality strategies into providing well governed community 
acute and post acute care.  
In 2005 there were 163 video conferencing sessions conducted. All of these included case conferencing and 
139 also involved professional development sessions and 43 were associated with administrative activities. 
This poster will outline the characteristics of the use of Video Conferencing in Ambulatory Care and examines 
specific research data and basic cost-benefits. 
 
When does an egg not mean a chicken? Lack of symptom recognition of other comorbidities in 
COPD patients. 
 
Author: Hall T. Bendigo Health, VIC 
 
Bendigo Health is a regional health service provider with an established Hospital Admission Risk Program – 
Chronic Disease Management (HARP-CDM) service that includes Chronic Respiratory Diseases (asthma, 
emphysema); Chronic Heart Failure (CHF) and Care Coordination in the Emergency Department (ED).  Key 
strategies of this program aims to increase the capacity of the patient and the carer and of regional and rural 
health service providers in the ongoing management of these cohorts across the care continuum. 
It has become increasingly apparent that there is a lack of recognition and management of alternative causes 
for shortness of breath (SOB) for the COPD patient by acute and community health service providers.  
Consequently, COPD patients who experience increased shortness of breath at rest and/or on exertion with 
or without the presence of increased sputum production may be misdiagnosed as a worsening of their airways 
disease.  However, there may be an alternative reason for the shortness of breath that needs to be 
investigated and treated.  A delay in the recognition and management of comorbidities, results in less than 
optimal outcomes for patients, such as representation to hospital, increased length of stay and early death.   
Two case studies will be discussed focusing on heart failure as an alternative diagnosis and identifying the 
reasons that this problem occurs. Through ongoing education of health care providers, Bendigo’s HARP-CDM 
is aiming to increase the awareness that dyspnoea in known COPD clients may also be due to alternative 
conditions. Subsequently, by promoting early recognition of other comorbidities and early management this 
may improve client’s outcomes, reduce hospital presentations and length of stay and improve their general 
outcome.   
 
 
The Use of a Dementia Clinical Pathway in a Tertiary Psychiatric Hospital: An analysis of 
demographics, interventions and resource utilization. 
 
Authors: Hendriks M, Mahendran R, Chiam P C, Institute of Mental Health/Woodbridge 
Hospital, Singapore 
 
Introduction: Clinical Pathways are important tools to improve the quality of patient care and track delivery 
processes and resources used.  The Institute of Mental Health/Woodbridge Hospital has developed eleven 
clinical pathways.  In a profile of the hospital’s Psychiatric DRGs (2003), Dementia and Global Disturbances of 
Cerebral Function was in the top six diseases accounting for 90% of cases treated here (resource weight of 
1.37; length of stay of 36.4 days and a high trim point of 29 days).  With these factors in mind, a workgroup 
was formed to develop a clinical pathway (CP) for Dementia in November 2004.  
We report the socio-demographic and psychiatric profile of patients on the Dementia CP, the interventions 
and resources used and the effectiveness of the pathway. 
Method:  A survey form was designed to capture the data and staff involved in the development of the Clinical 
Pathway audited the medical records of the patients on CP. Data was coded into the SPSS system and 
analyzed. 
Results:  There were forty patients on the Dementia CP.  The majority  (92.5%) were aged >65years.  Of 
those below 65 years, two had multi-infarct dementia and one had a presenile dementia. There was an almost 
equal gender distribution with the majority (52.5%) widowed.  65% of the patients lived in Nursing Homes, 
with males 4.05 times more likely to live in such accommodations (p=0.041, OR=4.05, 95% CI=1.03 - 16.01). 
27.5% lived with their families and the rest with relatives/friends prior to admission.   95% of the patients had 
one or more medical comorbidities and 25% required transfer to the General Hospital for medical 
complications (for example, uncontrolled diabetes, acute myocardial infarction, anemia) during their 
psychiatric hospitalization.  50% of the patients were discharged within 21 days and 20% within 28 days.   
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All patients were assessed by a Multidisciplinary Team.  Treatment and care activities used included reality 
orientation, reminiscence and sensory stimulation, diversional therapy, behavioral intervention mobility 
program and modified Bartel Index.   
Conclusion:  The data analysis profiles and broadens our knowledge of the dementia inpatients’ psychiatric 
resource utilization patterns.  It will also assist the treatment team in developing programs to further facilitate 
the smooth transition of dementia patients from the hospital to the community. 
 
 
A Whole of Community Approach to Chronic Disease Management 
 
Authors: McLauchlan L, Tozer J. Peninsula Health Complex Care Program, VIC 
 
Chronic disease management poses a special challenge for the health care system as people with chronic 
diseases use health services frequently and over an extended period of time.  Currently on the Peninsula, 
chronic disease management is fragmented in its delivery.  Each individual service has their own model of care, 
positioning the service needs at the centre of the model as opposed to the client/patient being the main focus.  
Through a comprehensive whole-of-community approach to chronic disease management, this project aims to 
implement substantial and sustainable change to the way the client progresses through the continuum of care.  
Our aim is to develop a model of care that provides an integrated continuum of care across time, throughout 
different stages of disease and co-morbidities, and across different services and service providers on the 
Peninsula.  
To achieve this we have developed a process tool that can be implemented for individual disease specific 
continuums.  It will identify and or clarify processes, service gaps and enable the development of a client 
focussed continuum of care across the community.  There are a number of steps to this process: 
♦ Step One: A forum with consumers and health care providers that work along the continuum 
from emergency services, acute, sub-acute, community and General Practitioners.  
♦ Step Two: Develop a working party from members of the forum.  
♦ Step Three: Identify gaps in service delivery along the continuum and develop recommendations 
to fill them.  
♦ Step Four: Develop a consistent client flow through the continuum of care involving all aspects of 
care. 
♦ Step Five: Form a Disease Specific Network that is self driven and sustainable, ensuring capacity to 
respond to changing needs.  
An overall outcome to date has been an increased knowledge of available services, the improvement in  
communication between services and the development of partnerships which the network would continue to  
foster. 
 
 
 
 
